Join the 200th Anniversary Celebration

Original Article

Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older

Bess Dawson-Hughes, M.D., Susan S. Harris, D.Sc., Elizabeth A. Krall, Ph.D., and Gerard E. Dallal, Ph.D.

N Engl J Med 1997; 337:670-676September 4, 1997

Abstract

Background

Inadequate dietary intake of calcium and vitamin D may contribute to the high prevalence of osteoporosis among older persons.

Methods

We studied the effects of three years of dietary supplementation with calcium and vitamin D on bone mineral density, biochemical measures of bone metabolism, and the incidence of nonvertebral fractures in 176 men and 213 women 65 years of age or older who were living at home. They received either 500 mg of calcium plus 700 IU of vitamin D3 (cholecalciferol) per day or placebo. Bone mineral density was measured by dual-energy x-ray absorptiometry, blood and urine were analyzed every six months, and cases of nonvertebral fracture were ascertained by means of interviews and verified with use of hospital records.

Results

The mean (±SD) changes in bone mineral density in the calcium–vitamin D and placebo groups were as follows: femoral neck, +0.50±4.80 and -0.70±5.03 percent, respectively (P = 0.02); spine, +2.12±4.06 and +1.22±4.25 percent (P = 0.04); and total body, +0.06±1.83 and -1.09±1.71 percent (P< 0.001). The difference between the calcium–vitamin D and placebo groups was significant at all skeletal sites after one year, but it was significant only for total-body bone mineral density in the second and third years. Of 37 subjects who had nonvertebral fractures, 26 were in the placebo group and 11 were in the calcium–vitamin D group (P = 0.02).

Conclusions

In men and women 65 years of age or older who are living in the community, dietary supplementation with calcium and vitamin D moderately reduced bone loss measured in the femoral neck, spine, and total body over the three-year study period and reduced the incidence of nonvertebral fractures.

Media in This Article

Figure 1Cumulative Percentage of All 389 Subjects with a First Nonvertebral Fracture, According to Study Group.
Table 1Base-Line Characteristics of the 389 Study Subjects.
Article

Inadequate intake of calcium and vitamin D leads to reduced calcium absorption, increased serum parathyroid hormone concentrations, and bone loss. Low bone mass is a strong predictor of fracture.1 Supplemental calcium reduces bone loss in middle-aged, postmenopausal women2-8 and lowers rates of vertebral fracture in women with previous vertebral fractures.9 Supplementation with vitamin D alone reduced bone loss from the femoral neck in postmenopausal women,10,11 but it did not reduce the rate of hip fracture among elderly Dutch men and women.12 Annual intramuscular injections of vitamin D did, however, reduce rates of arm fracture among elderly Finnish subjects.13

There is a rationale for supplementing the diets of elderly subjects with a combination of calcium and vitamin D. Absorption of calcium14 and possibly of vitamin D15 and production of vitamin D16 by the skin decline with aging. Diets that are deficient in calcium tend also to be deficient in vitamin D because a single food, milk, is the principal dietary source of both these nutrients. Combined calcium and vitamin D supplementation has reduced rates of nonvertebral fracture among elderly women living in retirement homes.17 In the one available study of men (mean age, 58 years) who lived at home, calcium and vitamin D together did not reduce bone loss.18 The role of combined supplements in elderly men and women living at home is unknown. We examined the effects of combined calcium and vitamin D supplementation on bone loss, biochemical measures of bone metabolism, and the incidence of nonvertebral fractures in men and women 65 years of age or older who were living in the community.

Methods

Subjects

We studied only healthy, ambulatory men and women 65 years of age or older who were recruited through direct mailings and presentations in the community. The criteria for exclusion included current cancer or hyperparathyroidism; a kidney stone in the past five years; renal disease; bilateral hip surgery; therapy with a bisphosphonate, calcitonin, estrogen, tamoxifen, or testosterone in the past six months or fluoride in the past two years; femoral-neck bone mineral density more than 2 SD below the mean for subjects of the same age and sex; dietary calcium intake exceeding 1500 mg per day; and laboratory evidence of kidney or liver disease.

We prescreened 848 subjects by means of a questionnaire and invited 545 for screening. Of these, 51 were found to be ineligible, 49 were potentially eligible but were not enrolled, and 445 (199 men and 246 women) were enrolled. There were 430 whites, 11 blacks, and 4 Asians. The protocol was approved by the Human Investigation Review Committee at Tufts University, and written informed consent was obtained from each subject.

Study Design and Supplements

In this three-year, double-blind, placebo-controlled trial, the subjects were randomly assigned to either the placebo or the calcium–vitamin D group with stratification according to sex, race, and decade of age. At study entry, we performed physical examinations and assessed the subjects' medical history, diet, and physical-activity level; analyzed blood and urine; and measured bone mineral density. The subjects were advised to maintain their usual diets and to avoid taking supplemental calcium and vitamin D on their own for two months before and throughout the study. At bedtime, the subjects took separate pills containing 500 mg of elemental calcium in the form of calcium citrate malate19 and 700 IU of cholecalciferol or separate placebo tablets containing microcrystalline cellulose.

Calcium citrate malate (Procter & Gamble, Cincinnati) was prepared in two batches; assays confirmed that the contents were as expected. The vitamin D tablets used initially contained 707 IU; two years later, the tablets were found to contain 563 IU (80 percent) of the planned dose of 700 IU; a second lot initially containing 768 IU was used during the second half of the study. The tablets were stored in opaque bottles at room temperature.

Status of Subjects and Compliance

During the trial, 127 subjects discontinued treatment; 4 died, 40 stopped for personal reasons (e.g., they lost interest or moved away), 46 withdrew because of illness, 17 started estrogen or glucocorticoid therapy, and 20 withdrew because of problems with the medication. The majority of subjects who discontinued treatment did so in the first year. These subjects were encouraged to return for all subsequent follow-up evaluations. At the last visit, 389 subjects (87 percent of the 445 enrolled) were evaluated and were included in the main intention-to-treat analyses. The 318 subjects who remained in the two study groups (i.e., those who took the supplements throughout the study period) were included in the analyses of subjects who completed the study according to the protocol.

The mean (±SD) rate of compliance with treatment, assessed on the basis of pill counts, was 92±10 percent for the calcium or placebo tablets and 93±10 percent for the vitamin D or placebo tablets among the 318 subjects who completed the study.

Measurements

The subjects came to the center every six months for measurements of bone mineral density, biochemical assays, and other measurements. Their calcium and vitamin D intake was estimated on the basis of a food-frequency questionnaire.20 During the study, 44 of the subjects who completed the study treatment (23 in the placebo group and 21 in the calcium–vitamin D group) reported taking products that contained some calcium or vitamin D. They were asked to stop taking these products, and the intake from supplements was added to their dietary intake during the relevant period. Leisure, household, and occupational activity was estimated with use of the Physical Activity Scale for the Elderly questionnaire.21 Tobacco use was determined by questionnaire. Height was measured with a stadiometer, and weight with a digital scale.

The subjects were asked to send in a postcard after any fall. When such a postcard was received, a staff member called the subject to verify the circumstances. Subjects reported any additional falls at each follow-up visit. Nonvertebral fractures were identified during interviews at the same visits. The principal investigator, who was unaware of the subjects' study-group assignments, classified the fractures as nonosteoporotic (resulting from severe trauma) or osteoporotic (resulting from moderate-to-minor trauma — i.e., a fall from standing height or less). All but one nonvertebral fracture (a presumed toe fracture that was not treated) were verified by review of x-ray reports or hospital records.

Analytic Methods

Bone mineral density in the hip, spine, and total body was measured by dual-energy x-ray absorptiometry with use of a DPX-L scanner (Lunar Radiation, Madison, Wis.). Scanner software versions 1.2 and 1.3y were used for data acquisition and analysis, respectively. The coefficients of variation for the measurements were 2.0 percent (femoral neck), 1.0 percent (spine), and 0.6 percent (total body). The scans of the hip were performed in duplicate, with repositioning between scans, and the values were averaged. A phantom consisting of bone ash embedded in a 12-cm block was scanned every other week as a control; the bone mineral density of the phantom was stable throughout the study.

Blood was drawn between 7:00 and 9:30 a.m. after the subjects had fasted for at least eight hours. Urine measurements were made in 24-hour collections. Plasma 25-hydroxyvitamin D was measured by the method of Preece et al.,22 plasma 1,25-dihydroxyvitamin D by a competitive protein-binding method,23 serum parathyroid hormone by immunometric assay (Nichols Institute, San Juan Capistrano, Calif.), serum osteocalcin by immunoradiometric assay (Nichols Institute), urinary N-telopeptide cross-links by enzyme-linked immunosorbent assay (Ostex International, Seattle), and serum ionized calcium and urinary calcium and creatinine as reported previously.20 The coefficients of variation for these assays ranged from 5.6 percent to 7.7 percent. Analyses were performed as the samples were collected, except for the plasma 1,25-dihydroxyvitamin D and urinary N-telopeptide assays, for which initial and final samples were analyzed at the same time.

Statistical Analysis

Comparisons between the study groups were made with two-sample t-tests and, when adjustments were required, with analysis of covariance. Terms for the interaction of sex and study group in analysis-of-variance models of the change in bone mineral density were statistically significant only at the femoral neck in the subjects in the intention-to-treat analysis; this term did not remain significant after adjustment for the duration of treatment. The relative risks of fracture among the subjects in the calcium–vitamin D and placebo groups were compared by means of the chi-square test. Analyses were conducted with SPSS (SPSS Inc., Chicago) and SAS (SAS Institute, Cary, N.C.) software. All P values are two-sided. Intention-to-treat analyses were conducted according to the principles described by Newell24; selected secondary analyses were restricted to subjects who completed the study.

Results

The base-line characteristics of the 389 subjects are shown in Table 1Table 1Base-Line Characteristics of the 389 Study Subjects.. As compared with placebo, supplementation with calcium and vitamin D had a significant positive effect on the change over three years in bone mineral density measured at the femoral neck, spine, and total body in all subjects together and in the men (Table 2Table 2Change in Bone Mineral Density over Three Years in All Subjects and in Subjects Who Completed the Study.). The women in the calcium–vitamin D group had significantly less total-body bone loss than those in the placebo group; the differences in the changes at the femoral neck and spine were smaller and not statistically significant. Adjustment for differences between the study groups in base-line bone mineral density and calcium intake did not alter the results.

The time course of the response to treatment was examined in the 318 subjects who completed the study. Their clinical characteristics and bone mineral density at base line did not differ significantly from those of subjects who discontinued the study treatment, except that smoking was more prevalent in the latter group (10 percent, as compared with 4 percent among those who completed the study; P = 0.02). During the first year there was significantly less bone loss at the hip, spine, and total body in the calcium–vitamin D group; during the second and third years, however, there was significantly less loss only in the total body (Table 3Table 3Rates of Change in Bone Mineral Density in 318 Subjects Who Completed the Study, According to the Duration of Treatment.).

Among the 318 subjects who completed the study, those treated with calcium and vitamin D had significantly greater changes in a number of biochemical measures of bone metabolism (Table 4Table 4Initial Laboratory Values and Changes at Three Years in 313 Subjects Who Completed the Study, According to Study Group.). Serum osteocalcin concentrations and urinary excretion of N-telopeptide were significantly lower in the men than in the women throughout the study (P = 0.005).

Among the 389 study subjects, 37 (5 men and 32 women) had at least one nonvertebral fracture during the study period. The cumulative incidence of a first fracture at three years was 5.9 percent in the calcium–vitamin D group and 12.9 percent in the placebo group (relative risk, 0.5; 95 percent confidence interval, 0.2 to 0.9; P = 0.02) (Table 5Table 5Number of First Nonvertebral Fractures among All Subjects, According to Skeletal Site. and Figure 1Figure 1Cumulative Percentage of All 389 Subjects with a First Nonvertebral Fracture, According to Study Group.). Among the women in the placebo group, the incidence of fractures at three years was 19.6 percent. Twenty-eight subjects (76 percent) had fractures classified as osteoporotic; the three-year cumulative incidence of a first osteoporotic fracture in the calcium–vitamin D group was lower than that in the placebo group (relative risk, 0.4; 95 percent confidence interval, 0.2 to 0.8; P = 0.01). Only two men, both in the placebo group, had osteoporotic fractures, and the best predictor of osteoporotic fracture was female sex (P<0.001). Among the 318 subjects who completed the study, the relative risk of any first nonvertebral fracture in the calcium–vitamin D group as compared with the placebo group was 0.4 (95 percent confidence interval, 0.2 to 1.0; P = 0.03), and that for fractures classified as osteoporotic was 0.4 (95 percent confidence interval, 0.2 to 1.1; P = 0.06). There was no significant difference between the treatment groups in the percentage of subjects who fell; among women, the number of falls per subject who fell was somewhat higher in the calcium–vitamin D group than in the placebo group (data not shown). Two women (one in each study group) had a second osteoporotic fracture during the study.

The supplements were generally well tolerated, but 11 subjects discontinued treatment because of difficulty swallowing the pills and 9 discontinued because of other side effects (in the placebo group: 2 because of epigastric distress and 1 because of flank pain; in the calcium–vitamin D group: 3 because of constipation, 1 because of epigastric distress, 1 because of sweating, and 1 because of hypercalciuria).

Discussion

In this study, dietary supplementation with calcium and vitamin D reduced bone loss moderately in men and women 65 years of age or older who were living in the community. Among the men, there was a significant effect of treatment at the hip, spine, and total body. In an earlier study by Orwoll et al., a similar regimen of calcium and vitamin D had no effect, perhaps because the men in that study were younger and had a higher mean calcium intake than the men we studied (1160 vs. about 700 mg per day).18 The reduction in total-body bone loss in women in this study was similar to that in other trials of calcium supplementation alone.3,4 The estimated differences in bone mineral density at the femoral neck and spine among the women in the two study groups were similar to those found in other studies,2-4,6,10,11,25 although the differences did not reach statistical significance in our study. The effect of supplementation in all subjects was similar to that in the subjects who completed the study, as would be expected, given the high degree of overlap between the two groups. Treatment caused few symptoms or side effects.

In both men and women, calcium–vitamin D supplementation reduced total-body bone loss not only in the first year (an effect that could be ascribed to the closure of bone-remodeling space26), but also in the second and third years, suggesting long-term effectiveness of supplementation in terms of the skeleton as a whole. The initial effects of supplementation at the hip and spine during year 1 were maintained but not increased during the ensuing two years of the study. Others have reported a cumulative benefit in terms of total-body3,4 and femoral-neck3 bone density with the use of higher doses of calcium in younger postmenopausal women. Spinal bone mineral density increased in both study groups, probably because of increases in osteoarthritis and aortic calcification.27,28

After three years of calcium–vitamin D supplementation, serum osteocalcin concentrations were 9 percent lower in the men and 14 percent lower in the women than at base line, indicating that supplementation led to a sustained reduction in the rate of bone remodeling. The lack of change in urinary N-telopeptide excretion may reflect the variability of this measurement. Our study confirms previous observations that the rate of bone turnover, as measured by urinary excretion of pyridinoline cross-links29 and serum osteocalcin concentrations,30 is lower in men than in women.

The reduction in the incidence of nonvertebral fractures in the calcium–vitamin D group should be interpreted with some caution, because of the small number of study subjects. Nonetheless, the magnitude of the reduction in the risk of fracture was similar to that reported in a study of more than 3400 elderly French women treated with 1200 mg of calcium plus 800 IU of vitamin D or placebo each day.17 In a study of 2600 elderly Dutch men and women, there was no reduction in the incidence of fractures among those given 400 IU of vitamin D daily (without calcium), as compared with those given placebo.12 Our results differ from those of the Dutch study, possibly by chance (we studied fewer subjects) or because the treatments differed. When comparing the three-year rates of nonvertebral fractures among women assigned to placebo in several recent trials, we found that the 19.6 percent rate in this study was intermediate between the 9 percent reported for women who were, on average, 7 years younger than our subjects31 and the 27 percent reported for women who were 13 years older.17 We do not know the individual contributions of calcium or vitamin D to the results in our study.

The limited effect of calcium and vitamin D on bone mineral density, which was evident primarily in year 1, seems unlikely to account for the constant decline in the rate of nonvertebral fractures during the three-year study. A treatment-induced reduction in the incidence of falls does not appear to account for the reduction in the rate of fractures, since the number of falls was similar in the two groups. The reduction in the rate of bone turnover may have influenced the fracture rate by reducing the potential for trabecular perforation and reducing cortical porosity.

In conclusion, calcium and vitamin D supplementation leads to a moderate reduction in bone loss and may substantially reduce the risk of nonvertebral fractures among men and women 65 years of age or older who live in the community.

Supported by a grant (AG10353) from the National Institutes of Health and by a contract (53-3K06-5-10) with the Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University.

This article does not necessarily reflect the views or policies of the U.S. Department of Agriculture, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.

We are indebted to the staff of the Calcium and Bone Metabolism and Nutrition Evaluation Laboratories for their important contributions to this study.

Source Information

From the Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, 711 Washington St., Boston, MA 02111, where reprint requests should be addressed to Dr. Dawson-Hughes.

References

References

  1. 1

    Melton LJ III, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993;8:1227-1233
    CrossRef | Web of Science | Medline

  2. 2

    Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878-883
    Full Text | Web of Science | Medline

  3. 3

    Aloia JF, Vaswani A, Yeh JK, Ross PL, Flaster E, Dilmanian FA. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 1994;120:97-103
    Web of Science | Medline

  4. 4

    Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 1995;98:331-335
    CrossRef | Web of Science | Medline

  5. 5

    Chevalley T, Rizzoli R, Nydegger V, et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos Int 1994;4:245-252
    CrossRef | Web of Science | Medline

  6. 6

    Elders PJM, Netelenbos JC, Lips P, et al. Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 1991;73:533-540
    CrossRef | Web of Science | Medline

  7. 7

    Riis B, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med 1987;316:173-177
    Full Text | Web of Science | Medline

  8. 8

    Prince R, Devine A, Dick I, et al. The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women. J Bone Miner Res 1995;10:1068-1075
    CrossRef | Web of Science | Medline

  9. 9

    Recker RR, Hinders S, Davies KM, et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 1996;11:1961-1966
    CrossRef | Web of Science | Medline

  10. 10

    Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G, Green CL. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995;61:1140-1145
    Web of Science | Medline

  11. 11

    Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJF, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995;80:1052-1058
    CrossRef | Web of Science | Medline

  12. 12

    Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med 1996;124:400-406
    Web of Science | Medline

  13. 13

    Heikinheimo RJ, Inkovaara JA, Harju EJ, et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992;51:105-110
    CrossRef | Web of Science | Medline

  14. 14

    Bullamore JR, Wilkinson R, Gallagher JC, Nordin BEC, Marshall DH. Effect of age on calcium absorption. Lancet 1970;2:535-537
    CrossRef | Web of Science | Medline

  15. 15

    Barragry JM, France MW, Corless D, et al. Intestinal cholecalciferol absorption in the elderly and in younger adults. Clin Sci Mol Med 1978;55:213-220
    Medline

  16. 16

    MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536-1538
    CrossRef | Web of Science | Medline

  17. 17

    Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calciumto prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-1642
    Full Text | Web of Science | Medline

  18. 18

    Orwoll ES, Oviatt SK, McClung MR, Deftos LJ, Sexton G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 1990;112:29-34
    Web of Science | Medline

  19. 19

    Smith KT, Heaney RP, Flora L, Hinders SM. Calcium absorption from a new calcium delivery system (CCM). Calcif Tissue Int 1987;41:351-352
    CrossRef | Web of Science | Medline

  20. 20

    Krall EA, Sahyoun N, Tannenbaum S, Dallal GE, Dawson-Hughes B. Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 1989;321:1777-1783
    Full Text | Web of Science | Medline

  21. 21

    Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 1993;46:153-162
    CrossRef | Web of Science | Medline

  22. 22

    Preece MA, O'Riordan JL, Lawson DE, Kodicek E. A competitive protein-binding assay for 25-dihydroxycholecalciferol and 25-hydroxyergocalciferol in serum. Clin Chim Acta 1974;54:235-242
    CrossRef | Web of Science | Medline

  23. 23

    Reinhardt TA, Horst RL, Orf JW, Hollis BW. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 1984;58:91-98
    CrossRef | Web of Science | Medline

  24. 24

    Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol 1992;21:837-841
    CrossRef | Web of Science | Medline

  25. 25

    Ensrud KE, Palermo L, Black DM, et al. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 1995;10:1778-1787
    CrossRef | Web of Science | Medline

  26. 26

    Remodeling as a determinant of envelope physiology. In: Frost HM. Bone remodeling and its relationship to metabolic bone diseases. Orthopedic lectures. Vol. 3. Springfield, Ill.: Charles C Thomas, 1973:28-53.

  27. 27

    Jones G, Nguyen T, Sambrook P, Kelly PJ, Eisman JA. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994;309:691-695
    CrossRef | Web of Science | Medline

  28. 28

    Greenspan SL, Maitland LA, Myers ER, Krasnow MB, Kido TH. Femoral bone loss progresses with age: a longitudinal study in women over age 65. J Bone Miner Res 1994;9:1959-1965
    CrossRef | Web of Science | Medline

  29. 29

    Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 1993;8:643-648
    CrossRef | Web of Science | Medline

  30. 30

    Epstein S, Poser J, McClintock R, Johnston CC Jr, Bryce G, Hui S. Differences in serum bone GLA protein with age and sex. Lancet 1984;1:307-310
    CrossRef | Web of Science | Medline

  31. 31

    Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437-1443
    Full Text | Web of Science | Medline

Citing Articles (617)

Citing Articles

  1. 1

    L. Shepstone, R. Fordham, E. Lenaghan, I. Harvey, C. Cooper, N. Gittoes, A. Heawood, T. J. Peters, T. O’Neill, D. Torgerson, R. Holland, A. Howe, T. Marshall, J. A. Kanis, E. McCloskey. (2012) A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study. Osteoporosis International
    CrossRef

  2. 2

    Yasuhito Terabe, Atsushi Harada, Haruhiko Tokuda, Hiroyasu Okuizumi, Masahiro Nagaya, Hiroshi Shimokata. (2012) Vitamin D Deficiency in Elderly Women in Nursing Homes: Investigation with Consideration of Decreased Activation Function from the Kidneys. Journal of the American Geriatrics Societyn/a-n/a
    CrossRef

  3. 3

    Kevin D. Cashman, Anthony P. Fitzgerald, Mairead Kiely, Kelly M. Seamans. (2011) A systematic review and meta-regression analysis of the vitamin D intake–serum 25-hydroxyvitamin D relationship to inform European recommendations. British Journal of Nutrition 106:11, 1638-1648
    CrossRef

  4. 4

    Sunil J. Wimalawansa. (2011) Vitamin D: an essential component for skeletal health. Annals of the New York Academy of Sciences 1240:1, E1-E12
    CrossRef

  5. 5

    M. Manara. (2011) Le terapie farmacologiche nelle fratture da fragilità. Archivio di Ortopedia e Reumatologia 122:3-4, 20-21
    CrossRef

  6. 6

    La-or Chailurkit, S. Chanprasertyothin, S. Charoenkiatkul, N. Krisnamara, R. Rajatanavin, B. Ongphiphadhanakul. (2011) Malic enzyme gene polymorphism is associated with responsiveness in circulating parathyroid hormone after long-term calcium supplementation. The journal of nutrition, health & aging
    CrossRef

  7. 7

    John A. Kanis, Eugene McCloskey, Helena Johansson, Anders Oden, William D. Leslie. (2011) FRAX® with and without Bone Mineral Density. Calcified Tissue International
    CrossRef

  8. 8

    Marie-Paule Lecart, Jean-Yves Reginster. (2011) Current options for the management of postmenopausal osteoporosis. Expert Opinion on Pharmacotherapy 12:16, 2533-2552
    CrossRef

  9. 9

    Heike A. Bischoff-Ferrari. (2011) Relevance of vitamin D in muscle health. Reviews in Endocrine and Metabolic Disorders
    CrossRef

  10. 10

    Judith M. E. Walsh, Megan McNamara, Redonda G. Miller, Eleanor Bimla Schwarz. (2011) Update in Women’s Health for the General Internist. Journal of General Internal Medicine
    CrossRef

  11. 11

    John Anderson, Sanford Garner. 2011. Calcium and Bone. .
    CrossRef

  12. 12

    John Anderson, Sanford Garner. 2011. Nutrition and Bone Health. .
    CrossRef

  13. 13

    E. M. Abdel-Rahman, F. Turgut, K. Turkmen, R. A. Balogun. (2011) Falls in elderly hemodialysis patients. QJM 104:10, 829-838
    CrossRef

  14. 14

    T. G. Travison, G. R. Chiu, J. B. McKinlay, A. B. Araujo. (2011) Accounting for racial/ethnic variation in bone mineral content and density: the competing influences of socioeconomic factors, body composition, health and lifestyle, and circulating androgens and estrogens. Osteoporosis International 22:10, 2645-2654
    CrossRef

  15. 15

    Paul Lee. (2011) Vitamin D metabolism and deficiency in critical illness. Best Practice & Research Clinical Endocrinology & Metabolism 25:5, 769-781
    CrossRef

  16. 16

    María Victoria Salinas, Angela Zuleta, Patricia Ronayne, María Cecilia Puppo. (2011) Wheat Flour Enriched with Calcium and Inulin: A Study of Hydration and Rheological Properties of Dough. Food and Bioprocess Technology
    CrossRef

  17. 17

    Omar Khokhar, Timothy Lipman. 2011. Micronutrients. , 265-282.
    CrossRef

  18. 18

    C. L. Emmett, N. M. Redmond, T. J. Peters, S. Clarke, L. Shepstone, E. Lenaghan, A. R. G. Shaw. (2011) Acceptability of screening to prevent osteoporotic fractures in older women: a qualitative study. Family Practice
    CrossRef

  19. 19

    Jesús Alberto García Vadillo. (2011) Suplementos de calcio y vitamina D ¿para todos?: Pros. Reumatología Clínica 7, 34-39
    CrossRef

  20. 20

    Joan C. Lo, Sherri-Ann M. Burnett-Bowie, Joel S. Finkelstein. (2011) Bone and the Perimenopause. Obstetrics and Gynecology Clinics of North America 38:3, 503-517
    CrossRef

  21. 21

    Heike A. Bischoff-Ferrari. (2011) The Role of Falls in Fracture Prediction. Current Osteoporosis Reports 9:3, 116-121
    CrossRef

  22. 22

    A. J. Shepherd, A. R. Cass, L. A. Ray, A. Tan, G. S. Wilkinson. (2011) Treatment for older men with fractures. Osteoporosis International
    CrossRef

  23. 23

    Jacqueline H. Cole, Marjolein C. H. Meulen. (2011) Whole Bone Mechanics and Bone Quality. Clinical Orthopaedics and Related Research® 469:8, 2139-2149
    CrossRef

  24. 24

    Paul Lips, Natasja M. van Schoor. (2011) The effect of vitamin D on bone and osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 25:4, 585-591
    CrossRef

  25. 25

    Roxane Tenta, George Moschonis, Michael Koutsilieris, Yannis Manios. (2011) Calcium and vitamin D supplementation through fortified dairy products counterbalances seasonal variations of bone metabolism indices: the Postmenopausal Health Study. European Journal of Nutrition 50:5, 341-349
    CrossRef

  26. 26

    Ian R. Reid, Mark J. Bolland, Philip N. Sambrook, Andrew Grey. (2011) Calcium supplementation: Balancing the cardiovascular risks. Maturitas 69:4, 289-295
    CrossRef

  27. 27

    Hsiang-Hsi Hong, Ting-An Chou, Jen-Chang Yang, Chee-Jen Chang. (2011) The potential effects of cholecalciferol on bone regeneration in dogs. Clinical Oral Implants Researchn/a-n/a
    CrossRef

  28. 28

    T. Dinizulu, D. Griffin, J. Carey, E. Mulkerrin. (2011) Vitamin D supplementation versus combined calcium and vitamin D in older female patients — An observational study. The journal of nutrition, health & aging 15:8, 605-608
    CrossRef

  29. 29

    Goran Bjelakovic, Lise Lotte Gluud, Dimitrinka Nikolova, Kate Whitfield, Jørn Wetterslev, Rosa G Simonetti, Marija Bjelakovic, Christian Gluud, Goran Bjelakovic. 2011. Vitamin D supplementation for prevention of mortality in adults. .
    CrossRef

  30. 30

    Grahame J Elder. (2011) Calcium supplementation: lessons from the general population for chronic kidney disease and back. Current Opinion in Nephrology and Hypertension 20:4, 369-375
    CrossRef

  31. 31

    Camille E Powe, Catherine Ricciardi, Anders H Berg, Delger Erdenesanaa, Gina Collerone, Elizabeth Ankers, Julia Wenger, S Ananth Karumanchi, Ravi Thadhani, Ishir Bhan. (2011) Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. Journal of Bone and Mineral Research 26:7, 1609-1616
    CrossRef

  32. 32

    Michele Zini. (2011) Osteoporosi. La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine 7:2, 100-105
    CrossRef

  33. 33

    Deeptha Sukumar, Hasina Ambia-Sobhan, Robert Zurfluh, Yvette Schlussel, Theodore J Stahl, Chris L Gordon, Sue A Shapses. (2011) Areal and volumetric bone mineral density and geometry at two levels of protein intake during caloric restriction: A randomized, controlled trial. Journal of Bone and Mineral Research 26:6, 1339-1348
    CrossRef

  34. 34

    Siobhan Muldowney, Mairead Kiely. (2011) Vitamin D and cardiometabolic health: a review of the evidence. Nutrition Research Reviews 24:01, 1-20
    CrossRef

  35. 35

    Brian J. Gates, Shyamal Das. (2011) Management of osteoporosis in elderly men. Maturitas 69:2, 113-119
    CrossRef

  36. 36

    Erin Hommel, Adline Ghazi, Heidi White. (2011) Minimal Trauma Fractures: Lifting the Specter of Misconduct by Identifying Risk Factors and Planning for Prevention. Journal of the American Medical Directors Association
    CrossRef

  37. 37

    (2011) Managing osteoporosis in primary care: Highlights from Osteoporosis Canada guidelines. Canadian Pharmacists Journal 144:sp1, S5-S9.e1
    CrossRef

  38. 38

    Anthony J. Pellicane, Nicole M. Wysocki, Trudy R. Mallinson, Thomas J. Schnitzer. (2011) Prevalence of 25-Hydroxyvitamin D Deficiency in the Acute Inpatient Rehabilitation Population and Its Effect on Function. Archives of Physical Medicine and Rehabilitation 92:5, 705-711
    CrossRef

  39. 39

    Heike A Bischoff-Ferrari, Bess Dawson-Hughes, John A Baron, John A Kanis, Endel J Orav, Hannes B Staehelin, Douglas P Kiel, Peter Burckhardt, Jana Henschkowski, Donna Spiegelman, Ruifeng Li, John B Wong, Diane Feskanich, Walter C Willett. (2011) Milk intake and risk of hip fracture in men and women: A meta-analysis of prospective cohort studies. Journal of Bone and Mineral Research 26:4, 833-839
    CrossRef

  40. 40

    Linda Brewer, David Williams, Alan Moore. (2011) Current and future treatment options in osteoporosis. European Journal of Clinical Pharmacology 67:4, 321-331
    CrossRef

  41. 41

    V. Rabenda, O. Bruyère, J.-Y. Reginster. (2011) Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporosis International 22:3, 893-901
    CrossRef

  42. 42

    Geoffrey P. Webb. (2011) Vitamin fortification of foods: a critical review. Food Science & Technology Bulletin: Functional Foods 8:1, 1-11
    CrossRef

  43. 43

    José Manuel Quesada Gómez, Josep Blanch Rubió, Manuel Díaz Curiel, Adolfo Díez Pérez. (2011) Calcium Citrate and Vitamin D in the Treatment of Osteoporosis. Clinical Drug Investigation1
    CrossRef

  44. 44

    Tilman Todenhoefer, Georgios Gakis, David Schilling, Gerhard Feil, Christian Schwentner, Arnulf Stenzl. (2011) Diagnosis and treatment of prostate cancer-related bone disease. Clinical Investigation 1:2, 265-283
    CrossRef

  45. 45

    Ka Ying Ma, Nan Yang, Rui Jiao, Cheng Peng, Lei Guan, Yu Huang, Zhen-Yu Chen. (2011) Dietary calcium decreases plasma cholesterol by down-regulation of intestinal Niemann-Pick C1 like 1 and microsomal triacylglycerol transport protein and up-regulation of CYP7A1 and ABCG 5/8 in hamsters. Molecular Nutrition & Food Research 55:2, 247-258
    CrossRef

  46. 46

    Roderick J. Clifton-Bligh, Tuan V. Nguyen, Amy Au, Martyn Bullock, Ian Cameron, Robert Cumming, Jian Sheng Chen, Lyn M. March, Markus J. Seibel, Philip N. Sambrook. (2011) Contribution of a Common Variant in the Promoter of the 1-α-Hydroxylase Gene (CYP27B1) to Fracture Risk in the Elderly. Calcified Tissue International 88:2, 109-116
    CrossRef

  47. 47

    Edgar Turner Overton, Michael T. Yin. (2011) The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations. Current Infectious Disease Reports 13:1, 83-93
    CrossRef

  48. 48

    INAAM A. NAKCHBANDI. (2011) Commentary on Grey et al. (2011): Does methadone maintenance therapy adversely affect bone mass?. Addiction 106:2, 355-356
    CrossRef

  49. 49

    S. J. Whiting, H. Vatanparast. 2011. Functional foods and bone health. , 309-334.
    CrossRef

  50. 50

    Yoshihiro Sato, Jun Iwamoto, Yoshiaki Honda. (2011) Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson’s disease. Parkinsonism & Related Disorders 17:1, 22-26
    CrossRef

  51. 51

    Joel E Michalek, Harry G Preuss, Harry A Croft, Patti L Keith, Samuel C Keith, Monika Dapilmoto, Nicholas V Perricone, Robert B Leckie, Gilbert R Kaats. (2011) Changes in total body bone mineral density following a common bone health plan with two versions of a unique bone health supplement: a comparative effectiveness research study. Nutrition Journal 10:1, 32
    CrossRef

  52. 52

    Evelien Gielen, Steven Boonen, Dirk Vanderschueren, Mieke Sinnesael, Annemieke Verstuyf, Frank Claessens, Koen Milisen, Sabine Verschueren. (2011) Calcium and Vitamin D Supplementation in Men. Journal of Osteoporosis 2011, 1-6
    CrossRef

  53. 53

    Sabine MP Verschueren, An Bogaerts, Christophe Delecluse, Albrecht L Claessens, Patrick Haentjens, Dirk Vanderschueren, Steven Boonen. (2011) The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: A 6-month randomized, controlled trial. Journal of Bone and Mineral Research 26:1, 42-49
    CrossRef

  54. 54

    Patrick H. Biggar, Orfeas Liangos, Holger Fey, Vincent M. Brandenburg, Markus Ketteler. (2011) Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug?. Pediatric Nephrology 26:1, 7-18
    CrossRef

  55. 55

    Sarah E Lamb, Clemens Becker, Lesley D Gillespie, Jessica L Smith, Susanne Finnegan, Rachel Potter, Klaus Pfeiffer, . (2011) Reporting of complex interventions in clinical trials: development of a taxonomy to classify and describe fall-prevention interventions. Trials 12:1, 125
    CrossRef

  56. 56

    G. Leidig-Bruckner, H. J. Roth, T. Bruckner, A. Lorenz, F. Raue, K. Frank-Raue. (2011) Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels—an observational study during clinical practice conditions. Osteoporosis International 22:1, 231-240
    CrossRef

  57. 57

    Connie Weaver, Richard Lewis, Emma Laing. 2011. Adolescence and Acquisition of Peak Bone Mass. , 657-677.
    CrossRef

  58. 58

    Aasis Unnanuntana, Brian J. Rebolledo, Joseph M. Lane. 2011. The Role of Vitamin D in Orthopedic Surgery. , 927-944.
    CrossRef

  59. 59

    Heike Bischoff-Ferrari, Bess Dawson-Hughes. 2011. Relevance of Vitamin D Deficiency in Adult Fracture and Fall Prevention. , 1145-1153.
    CrossRef

  60. 60

    Peter R. Ebeling, John A. Eisman. 2011. Vitamin D and Osteoporosis. , 1129-1144.
    CrossRef

  61. 61

    E. Michael Lewiecki. (2010) Monitoring pharmacological therapy for osteoporosis. Reviews in Endocrine and Metabolic Disorders 11:4, 261-273
    CrossRef

  62. 62

    M. Kärkkäinen, M. Tuppurainen, K. Salovaara, L. Sandini, T. Rikkonen, J. Sirola, R. Honkanen, J. Jurvelin, E. Alhava, H. Kröger. (2010) Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65–71 years: a 3-year randomized population-based trial (OSTPRE-FPS). Osteoporosis International 21:12, 2047-2055
    CrossRef

  63. 63

    Diederik H.R. Kempen, Laura B. Creemers, Jacqueline Alblas, Lichun Lu, Abraham J. Verbout, Michael J. Yaszemski, Wouter J.A. Dhert. (2010) Growth Factor Interactions in Bone Regeneration. Tissue Engineering Part B: Reviews 16:6, 551-566
    CrossRef

  64. 64

    V. Rabenda, J.-Y. Reginster. (2010) Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures. Osteoporosis International 21:12, 1993-2002
    CrossRef

  65. 65

    Michael Pfeifer, Helmut W. Minne. (2010) Musculoskeletal rehabilitation after hip fracture: a review. Archives of Osteoporosis 5:1-2, 49-59
    CrossRef

  66. 66

    Anthony J. Pellicane, Nicole M. Wysocki, Thomas J. Schnitzer. (2010) Prevalence of 25-Hydroxyvitamin D Deficiency in the Outpatient Rehabilitation Population. American Journal of Physical Medicine & Rehabilitation 89:11, 899-904
    CrossRef

  67. 67

    Heikki Kröger, Matti Kärkkäinen, Risto Honkanen. (2010) Calcium and vitamin D in promotion of postmenopausal bone health. Women's Health 6:6, 773-776
    CrossRef

  68. 68

    J.-J. Body, P. Bergmann, S. Boonen, Y. Boutsen, J.-P. Devogelaer, S. Goemaere, J.-M. Kaufman, S. Rozenberg, J.-Y. Reginster. (2010) Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporosis International 21:10, 1657-1680
    CrossRef

  69. 69

    Hasan Onal, Erdal Adal, Seçil Alpaslan, Atilla Ersen, Ahmet Aydin. (2010) Is daily 400 IU of vitamin D supplementation appropriate for every country: a cross-sectional study. European Journal of Nutrition 49:7, 395-400
    CrossRef

  70. 70

    Paul Lips, Roger Bouillon, Natasja M. Van Schoor, Dirk Vanderschueren, Sabine Verschueren, Natalia Kuchuk, Koen Milisen, Steven Boonen. (2010) REVIEW ARTICLE: Reducing fracture risk with calcium and vitamin D. Clinical Endocrinology 73:3, 277-285
    CrossRef

  71. 71

    John J. Carey, Miriam F. Delaney. (2010) T-Scores and Z-Scores. Clinical Reviews in Bone and Mineral Metabolism 8:3, 113-121
    CrossRef

  72. 72

    Taison D. Bell, Marie B. Demay, Sherri-Ann M. Burnett-Bowie. (2010) The biology and pathology of vitamin D control in bone. Journal of Cellular Biochemistry 111:1, 7-13
    CrossRef

  73. 73

    Kari Salovaara, Marjo Tuppurainen, Matti Kärkkäinen, Toni Rikkonen, Lorenzo Sandini, Joonas Sirola, Risto Honkanen, Esko Alhava, Heikki Kröger. (2010) Effect of vitamin D3 and calcium on fracture risk in 65- to 71-year-old women: A population-based 3-year randomized, controlled trial-the OSTPRE-FPS. Journal of Bone and Mineral Research 25:7, 1487-1495
    CrossRef

  74. 74

    George Moschonis, Ioanna Katsaroli, George P. Lyritis, Yannis Manios. (2010) The effects of a 30-month dietary intervention on bone mineral density: The Postmenopausal Health Study. British Journal of Nutrition 104:01, 100-107
    CrossRef

  75. 75

    H. A. Bischoff-Ferrari, A. Shao, B. Dawson-Hughes, J. Hathcock, E. Giovannucci, W. C. Willett. (2010) Benefit–risk assessment of vitamin D supplementation. Osteoporosis International 21:7, 1121-1132
    CrossRef

  76. 76

    I. R. Reid. (2010) Vitamin D - Let's Get Back to the Evidence Base. IBMS BoneKEy 7:7, 249-253
    CrossRef

  77. 77

    Neil Binkley, Rekha Ramamurthy, Diane Krueger. (2010) Low Vitamin D Status: Definition, Prevalence, Consequences, and Correction. Endocrinology & Metabolism Clinics of North America 39:2, 287-301
    CrossRef

  78. 78

    Magdalena Bartoszewska, Manmohan Kamboj, Dilip R. Patel. (2010) Vitamin D, Muscle Function, and Exercise Performance. Pediatric Clinics of North America 57:3, 849-861
    CrossRef

  79. 79

    S. Devika C. Thomas, Allan G. Need, B. E. Christopher Nordin. (2010) Suppression of C-Terminal Telopeptide in Hypovitaminosis D Requires Calcium as Well as Vitamin D. Calcified Tissue International 86:5, 367-374
    CrossRef

  80. 80

    Kamil E Barbour, Joseph M Zmuda, Elsa S Strotmeyer, Mara J Horwitz, Robert Boudreau, Rhobert W Evans, Kristine E Ensrud, Moira A Petit, Christopher L Gordon, Jane A Cauley. (2010) Correlates of trabecular and cortical volumetric bone mineral density of the radius and tibia in older men: The osteoporotic fractures in men study. Journal of Bone and Mineral Research 25:5, 1017-1028
    CrossRef

  81. 81

    Francesc Casas, Josep María Borràs, Ferran Ferrer, Núria Guanyabens, Rafael Gutiérrez del Pozo, Concha León, José López Torrecilla, Begoña Mellado, Joan Morote, Manel Puig, María José Ribal, Carme Ruscalleda, Agustí Serra, Valentí Valls, Almudena Zapatero. (2010) Evidence-based consensus recommendations to improve the quality of life in prostate cancer treatment. Clinical and Translational Oncology 12:5, 346-355
    CrossRef

  82. 82

    Debby Uyl, Piet P. M. M. Geusens, Frank N. R. Berkum, Harry H. M. L. Houben, Max C. Jebbink, Willem F. Lems. (2010) Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial. Clinical Rheumatology 29:5, 465-472
    CrossRef

  83. 83

    Gert J.D. Bergman, Tao Fan, Jeffrey T. McFetridge, Shuvayu S. Sen. (2010) Efficacy of vitamin D 3 supplementation in preventing fractures in elderly women: A meta-analysis. Current Medical Research and Opinion 26:5, 1193-1201
    CrossRef

  84. 84

    Eric S. Orwoll, Neil C. Binkley, E. Michael Lewiecki, Ugis Gruntmanis, Michael A. Fries, Gorana Dasic. (2010) Efficacy and safety of monthly ibandronate in men with low bone density. Bone 46:4, 970-976
    CrossRef

  85. 85

    María Luz Pita Martin Portela, Amália Mónico, Antonieta Barahona, Hernan Dupraz, Macarena Maria Sol Gonzales-Chaves, Susana Noemi Zeni. (2010) Comparative 25-OH-vitamin D level in institutionalized women older than 65 years from two cities in Spain and Argentina having a similar solar radiation index. Nutrition 26:3, 283-289
    CrossRef

  86. 86

    Patrice Fardellone, François-Emery Cotté, Christian Roux, Eric Lespessailles, Florence Mercier, Anne-Françoise Gaudin. (2010) Calcium intake and the risk of osteoporosis and fractures in French women. Joint Bone Spine 77:2, 154-158
    CrossRef

  87. 87

    R. K. Chaganti, N. Parimi, P. Cawthon, T. L. Dam, M. C. Nevitt, N. E. Lane. (2010) Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: The osteoporotic fractures in men study. Arthritis & Rheumatism 62:2, 511-514
    CrossRef

  88. 88

    Matthias Priemel, Christoph von Domarus, Till Orla Klatte, Steffen Kessler, Julia Schlie, Simon Meier, Nils Proksch, Frederic Pastor, Clemens Netter, Thomas Streichert, Klaus Püschel, Michael Amling. (2010) Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. Journal of Bone and Mineral Research 25:2, 305-312
    CrossRef

  89. 89

    J. Almirall, M. Vaqueiro, M. L. Bare, E. Anton. (2010) Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly. Nephrology Dialysis Transplantation 25:2, 503-509
    CrossRef

  90. 90

    Teun M. Post, Serge C.L.M. Cremers, Thomas Kerbusch, Meindert Danhof. (2010) Bone Physiology, Disease and Treatment. Clinical Pharmacokinetics 49:2, 89-118
    CrossRef

  91. 91

    B. Bouvard, E. Hopp, D. Chappard, M. Audran, E. Legrand. (2010) Osteoporosis masculina. EMC - Aparato Locomotor 43:4, 1-7
    CrossRef

  92. 92

    Naohisa Miyakoshi, Hiroshi Sasaki, Yuji Kasukawa, Keiji Kamo, Yoichi Shimada. (2010) Effects of a vitamin D analog, alfacalcidol, on bone and skeletal muscle in glucocorticoid-treated rats. Biomedical Research 31:6, 329-336
    CrossRef

  93. 93

    L ARMAS. 2010. Calcium, Bone Strength and Fractures. , 235-241.
    CrossRef

  94. 94

    R BOUILLON. 2010. Vitamin D and Bone. , 243-253.
    CrossRef

  95. 95

    E ORWOLL. 2010. Overall Approach to the Evaluation and Treatment of Osteoporosis in Men. , 589-601.
    CrossRef

  96. 96

    D ANTONIUCCI. 2010. Nutritional Therapy for Skeletal Health in Men. , 629-633.
    CrossRef

  97. 97

    David Borradale, Michael Kimlin. (2009) Vitamin D in health and disease: an insight into traditional functions and new roles for the ‘sunshine vitamin’. Nutrition Research Reviews 22:02, 118
    CrossRef

  98. 98

    Carolina R. C. Doorenbos, Jacob van den Born, Gerjan Navis, Martin H. de Borst. (2009) Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nature Reviews Nephrology 5:12, 691-700
    CrossRef

  99. 99

    P. Kilpinen-Loisa, M. Arvio, V. Ilvesmäki, O. Mäkitie. (2009) Vitamin D status and optimal supplementation in institutionalized adults with intellectual disability. Journal of Intellectual Disability Research 53:12, 1014-1023
    CrossRef

  100. 100

    Asma Arabi, Laila Zahed, Ziyad Mahfoud, Lina El-Onsi, Mona Nabulsi, Joyce Maalouf, Ghada El-Hajj Fuleihan. (2009) Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls. Bone 45:6, 1091-1097
    CrossRef

  101. 101

    Paul Glendenning, Gerard T. Chew, Hannah M. Seymour, Melissa J. Gillett, Peter R. Goldswain, Charles A. Inderjeeth, Samuel D. Vasikaran, Mario Taranto, Alexander A. Musk, William D. Fraser. (2009) Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 45:5, 870-875
    CrossRef

  102. 102

    S. Sahni, M. T. Hannan, D. Gagnon, J. Blumberg, L. A. Cupples, D. P. Kiel, K. L. Tucker. (2009) Protective effect of total and supplemental vitamin C intake on the risk of hip fracture—a 17-year follow-up from the Framingham Osteoporosis Study. Osteoporosis International 20:11, 1853-1861
    CrossRef

  103. 103

    Jing Yong Siow, Pauline Siew Mei Lai, Siew Siang Chua, Siew Pheng Chan. (2009) The impact of pharmacist intervention on the use of activated vitamin D in a tertiary referral hospital in Malaysia. International Journal of Pharmacy Practice 17:5, 305-311
    CrossRef

  104. 104

    E. Michael Lewiecki. (2009) Current and Emerging Pharmacologic Therapies for the Management of Postmenopausal Osteoporosis. Journal of Women's Health 18:10, 1615-1626
    CrossRef

  105. 105

    H. A. BIschoff-Ferrari. (2009) Validated treatments and therapeutic perspectives regarding nutritherapy. The Journal of Nutrition, Health and Aging 13:8, 737-741
    CrossRef

  106. 106

    Arpita Patel Pitroda, Susan S. Harris, Bess Dawson-Hughes. (2009) The association of adiposity with parathyroid hormone in healthy older adults. Endocrine 36:2, 218-223
    CrossRef

  107. 107

    Sherry Huang, Jin Ching Chen, Chin Wei Hsu, Walter H Chang. (2009) Effects of nano calcium carbonate and nano calcium citrate on toxicity in ICR mice and on bone mineral density in an ovariectomized mice model. Nanotechnology 20:37, 375102
    CrossRef

  108. 108

    Chin Lee. (2009) Can healthy, older, nonosteoporotic men benefit from calcium supplementation?. Current Osteoporosis Reports 7:3, 73-74
    CrossRef

  109. 109

    Sarah A. Stechschulte, Robert S. Kirsner, Daniel G. Federman. (2009) Vitamin D: Bone and Beyond, Rationale and Recommendations for Supplementation. The American Journal of Medicine 122:9, 793-802
    CrossRef

  110. 110

    Neil Binkley. (2009) Is Vitamin D the Fountain of Youth?. Endocrine Practice 15:6, 590-596
    CrossRef

  111. 111

    Nava Stoffman, Catherine M Gordon. (2009) Vitamin D and adolescents: what do we know?. Current Opinion in Pediatrics 21:4, 465-471
    CrossRef

  112. 112

    Sarah L. Booth. (2009) Roles for Vitamin K Beyond Coagulation. Annual Review of Nutrition 29:1, 89-110
    CrossRef

  113. 113

    Andrea Hacker-Thompson, Trina P. Robertson, Deborah E. Sellmeyer. (2009) Validation of Two Food Frequency Questionnaires for Dietary Calcium Assessment. Journal of the American Dietetic Association 109:7, 1237-1240
    CrossRef

  114. 114

    Yousra Hawli, Mona Nasrallah, Ghada El-Hajj Fuleihan. (2009) Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nature Reviews Endocrinology 5:6, 327-334
    CrossRef

  115. 115

    Jean-Philippe Bonjour, Léon Guéguen, Cristina Palacios, Martin J. Shearer, Connie M. Weaver. (2009) Minerals and vitamins in bone health: the potential value of dietary enhancement. British Journal of Nutrition 101:11, 1581
    CrossRef

  116. 116

    Supriya G. Mohile, Karen Mustian, Kathryn Bylow, William Hall, William Dale. (2009) Management of complications of androgen deprivation therapy in the older man. Critical Reviews in Oncology/Hematology 70:3, 235-255
    CrossRef

  117. 117

    Karl Michaelsson. (2009) The calcium quandary. Nutrition 25:6, 655-656
    CrossRef

  118. 118

    L. Lenaerts, G. H. van Lenthe. (2009) Multi-level patient-specific modelling of the proximal femur. A promising tool to quantify the effect of osteoporosis treatment. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 367:1895, 2079-2093
    CrossRef

  119. 119

    , Hans Peter Dimai, Peter Pietschmann, Heinrich Resch, Elisabeth Preisinger, Astrid Fahrleitner-Pammer, Harald Dobnig, Klaus Klaushofer. (2009) Österreichischer Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose – Update 2009. Wiener Medizinische Wochenschrift 159:S122, 1-34
    CrossRef

  120. 120

    Reiner Bartl. (2009) Prävention und Therapie der Osteoporose. Stellenwert von Calcium und Vitamin D. Pharmazie in unserer Zeit 38:3, 252-261
    CrossRef

  121. 121

    Alison Avenell, William J Gillespie, Lesley D Gillespie, Dianne O'Connell, Alison Avenell. 2009. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. .
    CrossRef

  122. 122

    Lesley D Gillespie, M Clare Robertson, William J Gillespie, Sarah E Lamb, Simon Gates, Robert G Cumming, Brian H Rowe, Lesley D Gillespie. 2009. Interventions for preventing falls in older people living in the community. .
    CrossRef

  123. 123

    Amy H. Warriner, Ryan C. Outman, Kenneth G. Saag, Sarah D. Berry, Cathleen Colón-Emeric, Kellie L. Flood, Kenneth W. Lyles, S Bobo Tanner, Nelson B. Watts, Jeffrey R. Curtis. (2009) Management of Osteoporosis Among Home Health and Long-Term Care Patients with a Prior Fracture. Southern Medical Journal 102:4, 397-404
    CrossRef

  124. 124

    Ralf Nass, Gudmundur Johannsson, Jens S. Christiansen, John J. Kopchick, Michael O. Thorner. (2009) The aging population – Is there a role for endocrine interventions?. Growth Hormone & IGF Research 19:2, 89-100
    CrossRef

  125. 125

    Heike Bischoff-Ferrari. (2009) Vitamin D in Fracture Prevention and Muscle Function and Fall Prevention. Clinical Reviews in Bone and Mineral Metabolism 7:1, 107-112
    CrossRef

  126. 126

    Wei-bo Xia, Zhong-lan Zhang, Hong-fu Wang, Xun-wu Meng, Ying Zhang, Guo-ying Zhu, Xiao-ping Xing, Jian-li Liu, Li-hua Wang, Yan Jiang, Shi-fang Weng, Tao Xu, Ying-ying Hu, Wei Yu, Jun-ping Tian. (2009) The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low bone mass. Acta Pharmacologica Sinica 30:3, 372-378
    CrossRef

  127. 127

    Michael F. Holick. (2009) Vitamin D and Health: Evolution, Biologic Functions, and Recommended Dietary Intakes for Vitamin D. Clinical Reviews in Bone and Mineral Metabolism 7:1, 2-19
    CrossRef

  128. 128

    M. R. Levinson, F. J. Clay. (2009) Barriers to the implementation of evidence in osteoporosis treatment in hip fracture. Internal Medicine Journal 39:3, 199-202
    CrossRef

  129. 129

    Mikko Björkman, Antti Sorva, Rejo Tilvis. (2009) Responses of parathyroid hormone to vitamin D supplementation: A systematic review of clinical trials. Archives of Gerontology and Geriatrics 48:2, 160-166
    CrossRef

  130. 130

    Leon. Lenchik. 2009. Dual X-Ray Absorptiometry. , 81-88.
    CrossRef

  131. 131

    T. Cederholm. 2009. Nutrition and bone health in the elderly. , 252-270.
    CrossRef

  132. 132

    Inan Anaforoglu, Asli Nar-Demirer, Neslihan Bascil-Tutuncu, Melek Eda Ertorer. (2009) Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes. Journal of Diabetes and its Complications 23:1, 12-17
    CrossRef

  133. 133

    M. Rodríguez, B. Daniels, S. Gunawardene, G.K. Robbins. (2009) High Frequency of Vitamin D Deficiency in Ambulatory HIV-Positive Patients. AIDS Research and Human Retroviruses 25:1, 9-14
    CrossRef

  134. 134

    Johann D. Ringe, Patrice Fardellone, Hans-Peter Kruse, Michael Amling, Stefan A.P. van der Geest, Gerd Möller. (2009) Value of a New Fixed-Combination Pack of Bisphosphonate, Calcium and Vitamin D in the Therapy of Osteoporosis. Drugs & Aging 26:3, 241-253
    CrossRef

  135. 135

    Zhao-Ming Zhong, Jian-Ting Chen. (2009) Anti-Fracture Efficacy of Risedronic Acid in Men. Clinical Drug Investigation 29:5, 349-357
    CrossRef

  136. 136

    Rogerio A. Lobo. 2009. Menopause and Aging. , 325-355.
    CrossRef

  137. 137

    Heike Bischoff-Ferrari, Henry W. Lim. 2008. Effect of Photoprotection on Vitamin D and Health. , 117-138.
    CrossRef

  138. 138

    Sarah D. Berry, Ram R. Miller. (2008) Falls: Epidemiology, pathophysiology, and relationship to fracture. Current Osteoporosis Reports 6:4, 149-154
    CrossRef

  139. 139

    Wei-Bo XIA, Ling XU, Hua SU. (2008) Vitamin D deficiency and osteoporosis. International Journal of Rheumatic Diseases 11:4, 366-373
    CrossRef

  140. 140

    S S Schleithoff, A Zittermann, G Tenderich, H K Berthold, P Stehle, R Koerfer. (2008) Combined calcium and vitamin D supplementation is not superior to calcium supplementation alone in improving disturbed bone metabolism in patients with congestive heart failure. European Journal of Clinical Nutrition 62:12, 1388-1394
    CrossRef

  141. 141

    T. Vogel, P. Kampmann, D. Bürklein, H. Böhm, B. Ockert, C. Kirchhoff, K.G. Kanz, K.J. Pfeifer, W. Mutschler. (2008) Versorgungswirklichkeit bei osteoporosebedingten Frakturen in der deutschen Unfallchirurgie. Der Unfallchirurg 111:11, 869-877
    CrossRef

  142. 142

    Melissa O. Premaor, Rosana Scalco, Marília J. S. Silva, Pedro E. Froehlich, Tania W. Furlanetto. (2008) The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. Journal of Bone and Mineral Metabolism 26:6, 603-608
    CrossRef

  143. 143

    Anne E Wolff, Andrea N Jones, Karen E Hansen. (2008) Vitamin D and musculoskeletal health. Nature Clinical Practice Rheumatology 4:11, 580-588
    CrossRef

  144. 144

    Peter J. Huth, Victor L. Fulgoni, Douglas B. DiRienzo, Gregory D. Miller. (2008) Role of Dairy Foods in the Dietary Guidelines. Nutrition Today 43:6, 226-234
    CrossRef

  145. 145

    Siobhan O’Donnell, David Moher, Kelli Thomas, David A. Hanley, Ann Cranney. (2008) Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. Journal of Bone and Mineral Metabolism 26:6, 531-542
    CrossRef

  146. 146

    David Thomas. 2008. Vitamins and Health in Older Persons. , 15-28.
    CrossRef

  147. 147

    Saeed Hosseini, Reza Ghiasvand. 2008. The Role of Diet in Slowing or Accelerating Aging. , 181-188.
    CrossRef

  148. 148

    Zhao Chen, Jeffrey Stanaway. 2008. Calcium and Vitamin D in Aging Populations. , 103-112.
    CrossRef

  149. 149

    Robert P Heaney. (2008) Vitamin D: criteria for safety and efficacy. Nutrition Reviews 66, S178-S181
    CrossRef

  150. 150

    René Rizzoli. (2008) Nutrition: its role in bone health. Best Practice & Research Clinical Endocrinology & Metabolism 22:5, 813-829
    CrossRef

  151. 151

    Jean-Philippe Bonjour, Marion Brandolini-Bunlon, Yves Boirie, Françoise Morel-Laporte, Véronique Braesco, Marie-Claude Bertière, Jean-Claude Souberbielle. (2008) Inhibition of bone turnover by milk intake in postmenopausal women. British Journal of Nutrition 100:04,
    CrossRef

  152. 152

    H. A. Bischoff-Ferrari, E. J. Orav, B. Dawson-Hughes. (2008) Additive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and women. Osteoporosis International 19:9, 1307-1314
    CrossRef

  153. 153

    ALLISON R. HAGEY, MICHELLE P. WARREN. (2008) Role of Exercise and Nutrition in Menopause. Clinical Obstetrics and Gynecology 51:3, 627-641
    CrossRef

  154. 154

    I. R. Reid, M. J. Bolland, A. Grey. (2008) Effect of calcium supplementation on hip fractures. Osteoporosis International 19:8, 1119-1123
    CrossRef

  155. 155

    Kun Zhu, David Bruce, Nicole Austin, Amanda Devine, Peter R Ebeling, Richard L Prince. (2008) Randomized Controlled Trial of the Effects of Calcium With or Without Vitamin D on Bone Structure and Bone-Related Chemistry in Elderly Women With Vitamin D Insufficiency. Journal of Bone and Mineral Research 23:8, 1343-1348
    CrossRef

  156. 156

    E. P. Cherniack, H. Florez, B. A. Roos, B. R. Troen, S. Levis. (2008) Hypovitaminosis D in the elderly: From bone to brain. The Journal of Nutrition Health and Aging 12:6, 366-373
    CrossRef

  157. 157

    Yun-Jung Bae, Mi-Hyun Kim. (2008) Manganese Supplementation Improves Mineral Density of the Spine and Femur and Serum Osteocalcin in Rats. Biological Trace Element Research 124:1, 28-34
    CrossRef

  158. 158

    J. F. Aloia, S. Arunabh-Talwar, S. Pollack, J. K. Yeh. (2008) The remodeling transient and the calcium economy. Osteoporosis International 19:7, 1001-1009
    CrossRef

  159. 159

    Rikke Andersen, Christian Mølgaard, Lene T. Skovgaard, Christine Brot, Kevin D. Cashman, Jette Jakobsen, Christel Lamberg-Allardt, Lars Ovesen. (2008) Effect of vitamin D supplementation on bone and vitamin D status among Pakistani immigrants in Denmark: a randomised double-blinded placebo-controlled intervention study. British Journal of Nutrition 100:01,
    CrossRef

  160. 160

    S.A. Holme, A.V. Anstey, M.N. Badminton, G.H. Elder. (2008) Serum 25-hydroxyvitamin D in erythropoietic protoporphyria. British Journal of Dermatology 159:1, 211-213
    CrossRef

  161. 161

    Mary Ann Johnson, Joan G. Fischer, Sohyun Park. (2008) Vitamin D Deficiency and Insufficiency in the Georgia Older Americans Nutrition Program. Journal of Nutrition For the Elderly 27:1-2, 29-46
    CrossRef

  162. 162

    Jean Woo, Christopher W. K. Lam, Jason Leung, Winny Y. Lau, Edith Lau, Xu Ling, Xiaoping Xing, Xi He Zhao, C. Murray Skeaff , Catherine J. Bacon, Jennifer E. P. Rockell, Aaron Lambert, Susan J. Whiting, Timothy J. Green. (2008) Very high rates of vitamin D insufficiency in women of child-bearing age living in Beijing and Hong Kong. British Journal of Nutrition 99:06,
    CrossRef

  163. 163

    William D. Leslie, Norine Miller, Linda Rogala, Charles N. Bernstein. (2008) Vitamin D Status and Bone Density in Recently Diagnosed Inflammatory Bowel Disease: The Manitoba IBD Cohort Study. The American Journal of Gastroenterology 103:6, 1451-1459
    CrossRef

  164. 164

    V. Chel, H. A. H. Wijnhoven, J. H. Smit, M. Ooms, P. Lips. (2008) Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporosis International 19:5, 663-671
    CrossRef

  165. 165

    Susan A. Lanham-New. (2008) Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment. Proceedings of the Nutrition Society 67:02, 163-176
    CrossRef

  166. 166

    J. W. Nieves, E. Barrett-Connor, E. S. Siris, M. Zion, S. Barlas, Y. T. Chen. (2008) Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporosis International 19:5, 673-679
    CrossRef

  167. 167

    Natasha Khazai, Suzanne E. Judd, Vin Tangpricha. (2008) Calcium and vitamin D: Skeletal and extraskeletal health. Current Rheumatology Reports 10:2, 110-117
    CrossRef

  168. 168

    Michelle A. Josephson. (2008) Vitamin D Deficiency in African American Kidney Transplant Recipients: Bringing a Common Problem to Light. Transplantation 85:5, 670-672
    CrossRef

  169. 169

    Erich Schacht. (2008) Reduction of falls and osteoporotic fractures: Plain vitamin D or D-hormone analogs?. Geriatrics & Gerontology International 8, S16-S25
    CrossRef

  170. 170

    M. Nabulsi, Z. Mahfoud, J. Maalouf, A. Arabi, G. E.-H. Fuleihan. (2008) Impact of maternal veiling during pregnancy and socioeconomic status on offspring’s musculoskeletal health. Osteoporosis International 19:3, 295-302
    CrossRef

  171. 171

    Jordan L. Geller, John S. Adams. (2008) Vitamin D therapy. Current Osteoporosis Reports 6:1, 5-11
    CrossRef

  172. 172

    T J Green, C M Skeaff, J E P Rockell, B J Venn, A Lambert, J Todd, G L Khor, S P Loh, S Muslimatun, R Agustina, S J Whiting. (2008) Vitamin D status and its association with parathyroid hormone concentrations in women of child-bearing age living in Jakarta and Kuala Lumpur. European Journal of Clinical Nutrition 62:3, 373-378
    CrossRef

  173. 173

    H.A. Bischoff-Ferrari, U. Can, H.B. Staehelin, A. Platz, J. Henschkowski, B.A. Michel, B. Dawson-Hughes, R. Theiler. (2008) Severe vitamin D deficiency in Swiss hip fracture patients. Bone 42:3, 597-602
    CrossRef

  174. 174

    Whitney S. Goldner, Julie A. Stoner, Jon Thompson, Karen Taylor, Luann Larson, Judi Erickson, Corrigan McBride. (2008) Prevalence of Vitamin D Insufficiency and Deficiency in Morbidly Obese Patients: A Comparison with Non-Obese Controls. Obesity Surgery 18:2, 145-150
    CrossRef

  175. 175

    R. Rizzoli, S. Boonen, M.L. Brandi, N. Burlet, P. Delmas, J.Y. Reginster. (2008) The role of calcium and vitamin D in the management of osteoporosis. Bone 42:2, 246-249
    CrossRef

  176. 176

    Adam M. Brufsky. (2008) Bone health issues in women with early-stage breast cancer receiving aromatase inhibitors. Current Oncology Reports 10:1, 18-26
    CrossRef

  177. 177

    Misa KOMATSU, Etsuko KAJITA, Junko TAMAKI, Yoshimi NAKATANI, Akiko YURA, Masayuki IKI. (2008) Japanese Journal of Health and Human Ecology 74:4, 164-177
    CrossRef

  178. 178

    Celestia S Higano. (2008) Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?. Nature Clinical Practice Urology 5:1, 24-34
    CrossRef

  179. 179

    Erin D Michos, Michal L Melamed. (2008) Vitamin D and cardiovascular disease risk. Current Opinion in Clinical Nutrition and Metabolic Care 11:1, 7-12
    CrossRef

  180. 180

    B.L. Clarke. (2008) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Yearbook of Endocrinology 2008, 208-210
    CrossRef

  181. 181

    Marci Goldstein Adams, Stacie Geller, Laura Studee. 2007. Menopause and Midlife. .
    CrossRef

  182. 182

    Connie M Weaver. (2007) Vitamin D, Calcium Homeostasis, and Skeleton Accretion in Children. Journal of Bone and Mineral Research 22:S2, V45-V49
    CrossRef

  183. 183

    Bess Dawson-Hughes, Heike A Bischoff-Ferrari. (2007) Therapy of Osteoporosis With Calcium and Vitamin D. Journal of Bone and Mineral Research 22:S2, V59-V63
    CrossRef

  184. 184

    J. D. Ringe, E. Schacht. (2007) Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol. Rheumatology International 28:2, 103-111
    CrossRef

  185. 185

    J.C. Talbot, C. Elener, P. Praveen, D.L. Shaw. (2007) Secondary prevention of osteoporosis: Calcium, Vitamin D and bisphosphonate prescribing following distal radial fracture. Injury 38:11, 1236-1240
    CrossRef

  186. 186

    P. J. Ryan. (2007) Vitamin D therapy in clinical practice. One dose does not fit all. International Journal of Clinical Practice 61:11, 1894-1899
    CrossRef

  187. 187

    Jennifer Grossman, Catherine H. MacLean. (2007) Quality Indicators for the Care of Osteoporosis in Vulnerable Elders. Journal of the American Geriatrics Society 55, S392-S402
    CrossRef

  188. 188

    E. Seeman. (2007) Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?. Bone 41:3, 308-317
    CrossRef

  189. 189

    Hosam K. Kamel. (2007) Update on Osteoporosis Management in Long-term Care: Focus on Bisphosphonates. Journal of the American Medical Directors Association 8:7, 434-440
    CrossRef

  190. 190

    BERDINE R. MARTIN, SHELLY DAVIS, WAYNE W. CAMPBELL, CONNIE M. WEAVER. (2007) Exercise and Calcium Supplementation. Medicine & Science in Sports & Exercise 39:9, 1481-1486
    CrossRef

  191. 191

    Sohyun Park, Mary Ann Johnson. 2007. Nutrition in Later Years. , 359-371.
    CrossRef

  192. 192

    A. Pavy-Le Traon, M. Heer, M. V. Narici, J. Rittweger, J. Vernikos. (2007) From space to Earth: advances in human physiology from 20 years of bed rest studies (1986–2006). European Journal of Applied Physiology 101:2, 143-194
    CrossRef

  193. 193

    H. A. Bischoff-Ferrari, J. E. Orav, J. A. Barrett, J. A. Baron. (2007) Effect of seasonality and weather on fracture risk in individuals 65 years and older. Osteoporosis International 18:9, 1225-1233
    CrossRef

  194. 194

    Ch. A. Barth. (2007) Zur wissenschaftlichen Grundlage von Nährwertprofilen. Ernährung - Wissenschaft und Praxis 1:6, 270-274
    CrossRef

  195. 195

    Jean-Yves Reginster. (2007) Calcium and vitamin D for osteoporotic fracture risk. The Lancet 370:9588, 632-634
    CrossRef

  196. 196

    Helena S. Salminen, Maria E. Sääf, Sven-Erik Johansson, Hans Ringertz, Lars-Erik Strender. (2007) The effect of transvaginal estradiol on bone in aged women: A randomised controlled trial. Maturitas 57:4, 370-381
    CrossRef

  197. 197

    Benjamin MP Tang, Guy D Eslick, Caryl Nowson, Caroline Smith, Alan Bensoussan. (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. The Lancet 370:9588, 657-666
    CrossRef

  198. 198

    Holick, Michael F., . (2007) Vitamin D Deficiency. New England Journal of Medicine 357:3, 266-281
    Full Text

  199. 199

    Beate Lanske, M Shawkat Razzaque. (2007) Mineral metabolism and aging: the fibroblast growth factor 23 enigma. Current Opinion in Nephrology and Hypertension 16:4, 311-318
    CrossRef

  200. 200

    Christopher W. Ryan, Dezheng Huo, James W. Stallings, Ronald L. Davis, Tomasz M. Beer, Laura T. McWhorter. (2007) Lifestyle Factors and Duration of Androgen Deprivation Affect Bone Mineral Density of Patients with Prostate Cancer During First Year of Therapy. Urology 70:1, 122-126
    CrossRef

  201. 201

    S. Y. Bu, E. A. Lucas, M. Franklin, D. Marlow, D. J. Brackett, E. A. Boldrin, L. Devareddy, B. H. Arjmandi, B. J. Smith. (2007) Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats. Osteoporosis International 18:7, 931-942
    CrossRef

  202. 202

    Matthew R Smith. (2007) Androgen deprivation therapy for prostate cancer: new concepts and concerns. Current Opinion in Endocrinology, Diabetes and Obesity 14:3, 247-254
    CrossRef

  203. 203

    S. M. Chatfield, C. Brand, P. R. Ebeling, D. M. Russell. (2007) Vitamin D deficiency in general medical inpatients in summer and winter. Internal Medicine Journal 37:6, 377-382
    CrossRef

  204. 204

    Sydney Bonnick, Susan Broy, Fran Kaiser, Carol Teutsch, Elizabeth Rosenberg, Paul DeLucca, Mary Melton. (2007) Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density. Current Medical Research and Opinion 23:6, 1341-1349
    CrossRef

  205. 205

    E. Tsiridis, Z. Gamie, P.G. Conaghan, P.V. Giannoudis. (2007) Biological options to enhance periprosthetic bone mass. Injury 38:6, 704-713
    CrossRef

  206. 206

    H. Resch, J. Walliser, S. Phillips, L. E. Wehren, S. S. Sen. (2007) Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective*. Current Medical Research and Opinion 23:6, 1227-1237
    CrossRef

  207. 207

    John A. Sunyecz, Richard Derman. (2007) Update on the Use of Bisphosphonates in the Management of Postmenopausal Osteoporosis by Obstetricians-Gynecologists. Obstetrical & Gynecological Survey 62:6, 407-416
    CrossRef

  208. 208

    R. T. C. M. Nordennen, V. G. G. Vanneste. (2007) Preventie en behandeling van osteoporose bij kortdurende revalidatie in het verpleeghuis: een taak voor de verpleeghuisarts. Tijdschrift voor Gerontologie en Geriatrie, 2007 38:3, 132-136
    CrossRef

  209. 209

    Ramzi Hajjar, Zeina Nahhas. 2007. Vitamin Disorders. , 137-178.
    CrossRef

  210. 210

    Kent Wehmeier. 2007. Nutrition and Fracture Risk. , 511-536.
    CrossRef

  211. 211

    Peter J Snyder, Beverly MK Biller, Anthony Zagar, Ivor Jackson, Baha M Arafah, Todd B Nippoldt, David M Cook, Arshag D Mooradian, Anita Kwan, Jamie Scism-Bacon, John J Chipman, Mark L Hartman. (2007) Effect of Growth Hormone Replacement on BMD in Adult-Onset Growth Hormone Deficiency. Journal of Bone and Mineral Research 22:5, 762-770
    CrossRef

  212. 212

    Antonella Barone, Andrea Giusti, Giulio Pioli, Giuseppe Girasole, Monica Razzano, Monica Pizzonia, Ernesto Palummeri, Gerolamo Bianchi. (2007) Secondary Hyperparathyroidism Due to Hypovitaminosis D Affects Bone Mineral Density Response to Alendronate in Elderly Women with Osteoporosis: A Randomized Controlled Trial. Journal of the American Geriatrics Society 55:5, 752-757
    CrossRef

  213. 213

    R. A. Lyons, A. Johansen, S. Brophy, R. G. Newcombe, C. J. Phillips, B. Lervy, R. Evans, K. Wareham, M. D. Stone. (2007) Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporosis International 18:6, 811-818
    CrossRef

  214. 214

    Caroline Bolton-Smith, Marion ET McMurdo, Colin R Paterson, Patricia A Mole, Julia M Harvey, Steven T Fenton, Celia J Prynne, Gita D Mishra, Martin J Shearer. (2007) Two-Year Randomized Controlled Trial of Vitamin K1 (Phylloquinone) and Vitamin D3 Plus Calcium on the Bone Health of Older Women. Journal of Bone and Mineral Research 22:4, 509-519
    CrossRef

  215. 215

    Jacques Planas, Juan Morote, Anna Orsola, Carlos Salvador, Enrique Trilla, Lluis Cecchini, Carles X. Raventós. (2007) The relationship between daily calcium intake and bone mineral density in men with prostate cancer. BJU International 99:4, 812-816
    CrossRef

  216. 216

    O. Johnell, F. Borgstrom, B. Jonsson, J. Kanis. (2007) Latitude, socioeconomic prosperity, mobile phones and hip fracture risk. Osteoporosis International 18:3, 333-337
    CrossRef

  217. 217

    P. Garnero, F. Munoz, E. Sornay-Rendu, P.D. Delmas. (2007) Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone 40:3, 716-722
    CrossRef

  218. 218

    Robert P. Heaney. (2007) The case for improving vitamin D status. The Journal of Steroid Biochemistry and Molecular Biology 103:3-5, 635-641
    CrossRef

  219. 219

    José A. Riancho, José L. Pérez-Castrillón, Carmen Valero, Jesús González-Macías. (2007) Ingesta de calcio insuficiente y fractura de cadera. Medicina Clínica 128:9, 355
    CrossRef

  220. 220

    Paul D. Miller. (2007) Monitoring osteoporosis therapies. Current Osteoporosis Reports 5:1, 38-43
    CrossRef

  221. 221

    Heike A. Bischoff-Ferrari. (2007) The 25-hydroxyvitamin D threshold for better health. The Journal of Steroid Biochemistry and Molecular Biology 103:3-5, 614-619
    CrossRef

  222. 222

    Ugis Gruntmanis. (2007) Male Osteoporosis: Deadly, but Ignored. The American Journal of the Medical Sciences 333:2, 85-92
    CrossRef

  223. 223

    Steven Boonen, Jean-Marc Kaufman, Stefan Goemaere, Roger Bouillon, Dirk Vanderschueren. (2007) The diagnosis and treatment of male osteoporosis: Defining, assessing, and preventing skeletal fragility in men. European Journal of Internal Medicine 18:1, 6-17
    CrossRef

  224. 224

    Alexandra Papaioannou, Courtney C Kennedy, Lisa Dolovich, Elaine Lau, Jonathan D Adachi. (2007) Patient Adherence to Osteoporosis Medications. Drugs & Aging 24:1, 37-55
    CrossRef

  225. 225

    Eugene V McCloskey, Monique Beneton, Diane Charlesworth, Karthik Kayan, Dominic de Takats, Abhijit Dey, Jane Orgee, Robert Ashford, Martin Forster, Jennifer Cliffe, Linda Kersh, John Brazier, Jon Nichol, Sakari Aropuu, Tarja Jalava, John A Kanis. (2007) Clodronate Reduces the Incidence of Fractures in Community-Dwelling Elderly Women Unselected for Osteoporosis: Results of a Double-Blind, Placebo-Controlled Randomized Study. Journal of Bone and Mineral Research 22:1, 135-141
    CrossRef

  226. 226

    Michael F Holick. (2007) Optimal Vitamin D Status for the Prevention and Treatment of Osteoporosis. Drugs & Aging 24:12, 1017-1029
    CrossRef

  227. 227

    Pamela Mason. (2007) One is okay, more is better? Pharmacological aspects and safe limits of nutritional supplements. Proceedings of The Nutrition Society 66:4,
    CrossRef

  228. 228

    2006. Dairy Foods and Bone Health. , 181-244.
    CrossRef

  229. 229

    Jean E Mulder, Nikheel S Kolatkar, Meryl S LeBoff. (2006) Drug Insight: existing and emerging therapies for osteoporosis. Nature Clinical Practice Endocrinology &#38; Metabolism 2:12, 670-680
    CrossRef

  230. 230

    Andrea L. Sikon, Holly L. Thacker, John Carey, Chad Deal, Angelo A. Licata. (2006) Secondary Osteoporosis: Are We Recognizing It?. Journal of Women's Health 15:10, 1174-1183
    CrossRef

  231. 231

    Frances BARNETT, Richard DE BOER. (2006) Cancer treatment-induced bone loss: A review. Asia-Pacific Journal of Clinical Oncology 2:4, 156-166
    CrossRef

  232. 232

    Cristina Palacios. (2006) The Role of Nutrients in Bone Health, from A to Z. Critical Reviews in Food Science and Nutrition 46:8, 621-628
    CrossRef

  233. 233

    Kevin D. Cashman. (2006) Milk minerals (including trace elements) and bone health. International Dairy Journal 16:11, 1389-1398
    CrossRef

  234. 234

    &NA;. (2006) The role of calcium in peri- and postmenopausal women. Menopause 13:6, 862-877
    CrossRef

  235. 235

    Hannah Piper, Tom Jaksic, Patrick Javid. 2006. Nutrition and Wound Healing at the Age Extremes. , 301-326.
    CrossRef

  236. 236

    Robin M. Daly, Shona Bass, Caryl Nowson. (2006) Long-term effects of calcium–vitamin-D3-fortified milk on bone geometry and strength in older men. Bone 39:4, 946-953
    CrossRef

  237. 237

    Laura B Hansen. (2006) Osteoporosis update: effective prevention and treatment. Expert Review of Pharmacoeconomics & Outcomes Research 6:5, 525-540
    CrossRef

  238. 238

    Silvina R. Mastaglia, Gretel G. Pellegrini, Patricia M. Mandalunis, Macarena M. Gonzales Chaves, Silvia M. Friedman, Susana N. Zeni. (2006) Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats. Bone 39:4, 837-844
    CrossRef

  239. 239

    C. Cormier, J.-C. Souberbielle. (2006) Nouvelles définitions de l'insuffisance vitaminique D, retentissement sur les normes de PTH. La Revue de Médecine Interne 27:9, 684-689
    CrossRef

  240. 240

    Simon Morr, Esteban Cuartas, Basil Alwattar, Joseph M. Lane. (2006) How Much Calcium Is in Your Drinking Water? A Survey of Calcium Concentrations in Bottled and Tap Water and Their Significance for Medical Treatment and Drug Administration. HSS Journal 2:2, 130-135
    CrossRef

  241. 241

    J. E. P. Rockell, C. M. Skeaff, S. M. Williams, T. J. Green. (2006) Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. Osteoporosis International 17:9, 1382-1389
    CrossRef

  242. 242

    Michael F. Holick. (2006) The role of vitamin D for bone health and fracture prevention. Current Osteoporosis Reports 4:3, 96-102
    CrossRef

  243. 243

    Juha-Petri Ruohola, Ilkka Laaksi, Timo Ylikomi, Riina Haataja, Ville M Mattila, Timo Sahi, Pentti Tuohimaa, Harri Pihlajamäki. (2006) Association Between Serum 25(OH)D Concentrations and Bone Stress Fractures in Finnish Young Men. Journal of Bone and Mineral Research 21:9, 1483-1488
    CrossRef

  244. 244

    S. Scharla. (2006) Stellenwert von nativem und biologisch aktivem Vitamin D bei der Prävention und Therapie der Osteoporose. Zeitschrift für Rheumatologie 65:5, 391-399
    CrossRef

  245. 245

    Ian McPhee Chapman. (2006) Nutritional Disorders in the Elderly. Medical Clinics of North America 90:5, 887-907
    CrossRef

  246. 246

    Robert Recker, Paul Lips, Dieter Felsenberg, Kurt Lippuner, Laurent Benhamou, Federico Hawkins, Pierre D. Delmas, Clifford Rosen, Ronald Emkey, Gretel Salzmann, Weili He, Arthur C. Santora. (2006) Alendronate with and without cholecalciferol for osteoporosis: results of a 15‐week randomized controlled trial*. Current Medical Research and Opinion 22:9, 1745-1755
    CrossRef

  247. 247

    Daniel Bunout, Gladys Barrera, Laura Leiva, Vivien Gattas, María Pía de la Maza, Marcelo Avendaño, Sandra Hirsch. (2006) Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects. Experimental Gerontology 41:8, 746-752
    CrossRef

  248. 248

    Asma Arabi, Rafic Baddoura, Hassane Awada, Mariana Salamoun, Ghazi Ayoub, Ghada El-Hajj Fuleihan. (2006) Hypovitaminosis D osteopathy: Is it mediated through PTH, lean mass, or is it a direct effect?. Bone 39:2, 268-275
    CrossRef

  249. 249

    R. Korpelainen, J. Korpelainen, J. Heikkinen, K. Väänänen, S. Keinänen-Kiukaanniemi. (2006) Lifelong risk factors for osteoporosis and fractures in elderly women with low body mass index—A population-based study. Bone 39:2, 385-391
    CrossRef

  250. 250

    Marilyn Norman, Martyn J. Parker. (2006) Compliance with a pharmacological secondary fracture prevention policy. Injury 37:8, 718-720
    CrossRef

  251. 251

    Cathleen S. Colón-Emeric, Kenneth G. Saag. (2006) Osteoporotic fractures in older adults. Best Practice & Research Clinical Rheumatology 20:4, 695-706
    CrossRef

  252. 252

    E Michael Lewiecki. (2006) Prevention of osteoporotic fractures. Aging Health 2:4, 649-659
    CrossRef

  253. 253

    Melanie Hingle, Renee Kishbaugh, Michael Buchwald, Lisa High. 2006. Skeletal System and Joint Health. .
    CrossRef

  254. 254

    Sergio Ragi-Eis, Cristiano A.F. Zerbini, José R. Provenza, Luiz H.M. Griz, Luiz H. de Gregório, Luis A.T. Russo, Nilzio A. Silva, João L.C. Borges, Antonio C.A. de Souza, Marize L. Castro, E. Michael Lewiecki. (2006) Is It Ethical to Use Placebos in Osteoporosis Trials?. Journal of Clinical Densitometry 9:3, 274-280
    CrossRef

  255. 255

    JESSICA CHUBAK, CORNELIA M. ULRICH, SHELLEY S. TWOROGER, BESS SORENSEN, YUTAKA YASUI, MELINDA L. IRWIN, FRANK Z. STANCZYK, JOHN D. POTTER, ANNE McTIERNAN. (2006) Effect of Exercise on Bone Mineral Density and Lean Mass in Postmenopausal Women. Medicine & Science in Sports & Exercise 38:7, 1236-1244
    CrossRef

  256. 256

    Leonid M. Shinchuk, Leslie Morse, Nadia Huancahuari, Seth Arum, Tai C. Chen, Michael F. Holick. (2006) Vitamin D Deficiency and Osteoporosis in Rehabilitation Inpatients. Archives of Physical Medicine and Rehabilitation 87:7, 904-908
    CrossRef

  257. 257

    Pooja Pothiwala, Ellen M. Evans, Karen M. Chapman-Novakofski. (2006) Ethnic Variation in Risk for Osteoporosis among Women: A Review of Biological and Behavioral Factors. Journal of Women's Health 15:6, 709-719
    CrossRef

  258. 258

    Kazutoshi Nakamura, Masayuki Iki. (2006) Efficacy of optimization of vitamin D in preventing osteoporosis and osteoporotic fractures: A systematic review. Environmental Health and Preventive Medicine 11:4, 155-170
    CrossRef

  259. 259

    Anne M. Kenny, Ilana Y. Waynik, JoAnne Smith, Richard Fortinsky, Alison Kleppinger, Daniel McGee. (2006) Association Between Level of Frailty and Bone Mineral Density in Community-Dwelling Men. Journal of Clinical Densitometry 9:3, 309-314
    CrossRef

  260. 260

    Ralph Müller, G. Harry van Lenthe. (2006) Trabecular bone failure at the microstructural level. Current Osteoporosis Reports 4:2, 80-86
    CrossRef

  261. 261

    S. BOONEN, D. VANDERSCHUEREN, P. HAENTJENS, P. LIPS. (2006) Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. Journal of Internal Medicine 259:6, 539-552
    CrossRef

  262. 262

    R. D. Semba, B. Bartali, J. Zhou, C. Blaum, C.-W. Ko, L. P. Fried. (2006) Low Serum Micronutrient Concentrations Predict Frailty Among Older Women Living in the Community. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:6, 594-599
    CrossRef

  263. 263

    D. McCarthy, A. Collins, M. O’Brien, C. Lamberg-Allardt, J. Jakobsen, J. Charzewska, M. Kiely, A. Flynn, K. D. Cashman. (2006) Vitamin D intake and status in Irish elderly women and adolescent girls. Irish Journal of Medical Science 175:2, 14-20
    CrossRef

  264. 264

    S. Boonen, H. A. Bischoff-Ferrari, C. Cooper, P. Lips, O. Ljunggren, P. J. Meunier, J.-Y. Reginster. (2006) Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence. Calcified Tissue International 78:5, 257-270
    CrossRef

  265. 265

    J. Daniell Rackley, Peter E. Clark, M. Craig Hall. (2006) Complementary and Alternative Medicine for Advanced Prostate Cancer. Urologic Clinics of North America 33:2, 237-246
    CrossRef

  266. 266

    Jean-Claude Souberbielle, Gérard Friedlander, André Kahan, Catherine Cormier. (2006) Evaluating vitamin D status. Implications for preventing and managing osteoporosis and other chronic diseases. Joint Bone Spine 73:3, 249-253
    CrossRef

  267. 267

    Scott M. Gilbert, James M. McKiernan. (2006) The Role of Bisphosphonates in Preventing Skeletal Complications of Hormonal Therapy. Urologic Clinics of North America 33:2, 191-199
    CrossRef

  268. 268

    &NA;. (2006) Management of osteoporosis in postmenopausal women. Menopause 13:3, 340-367
    CrossRef

  269. 269

    J. K. Dhesi, T. J. Allain, A. A. Mangoni, S. H. D. Jackson. (2006) The implications of a growing evidence base for drug use in elderly patients. Part 4. Vitamin D and bisphosphonates for fractures and osteoporosis. British Journal of Clinical Pharmacology 61:5, 521-528
    CrossRef

  270. 270

    S R Mastaglia, C A Mautalen, M S Parisi, B Oliveri. (2006) Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women. European Journal of Clinical Nutrition 60:5, 681-687
    CrossRef

  271. 271

    P Zubillaga, A Garrido, I Mugica, J Ansa, R Zabalza, J I Emparanza. (2006) Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with Down's Syndrome. European Journal of Clinical Nutrition 60:5, 605-609
    CrossRef

  272. 272

    Roger M Francis. (2006) Calcium, vitamin D and involutional osteoporosis. Current Opinion in Internal Medicine 5:2, 198-202
    CrossRef

  273. 273

    Philip E Lee, Janet E McElhaney, Larry Dian. (2006) Calcium and vitamin D supplementation for the prevention of fractures in postmenopausal women. Aging Health 2:2, 241-243
    CrossRef

  274. 274

    Daniel Couriel, Paul A. Carpenter, Corey Cutler, Javier Bolaños-Meade, Nathaniel S. Treister, Juan Gea-Banacloche, Paul Shaughnessy, Sharon Hymes, Stella Kim, Alan S. Wayne, Jason W. Chien, Joyce Neumann, Sandra Mitchell, Karen Syrjala, Carina K. Moravec, Linda Abramovitz, Jerry Liebermann, Ann Berger, Lynn Gerber, Mary Schubert, Alexandra H. Filipovich, Daniel Weisdorf, Mark M. Schubert, Howard Shulman, Kirk Schultz, Barbara Mittelman, Steven Pavletic, Georgia B. Vogelsang, Paul J. Martin, Stephanie J. Lee, Mary E.D. Flowers. (2006) Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation 12:4, 375-396
    CrossRef

  275. 275

    E. M. C. LAU, P. SAMBROOK, E. SEEMAN, K. H. LEONG, P. C. LEUNG, P. DELMAS. (2006) Guidelines for diagnosing, prevention and treatment of osteoporosis in Asia. APLAR Journal of Rheumatology 9:1, 24-36
    CrossRef

  276. 276

    2006. References. , 285-330.
    CrossRef

  277. 277

    Paul J. Drinka. (2006) The Importance of Parathyroid Hormone and Vitamin D Status in the Treatment of Osteoporosis and Renal Insufficiency. Journal of the American Medical Directors Association 7:3, S5-S9
    CrossRef

  278. 278

    A. Shiraishi, M. Ito, N. Hayakawa, N. Kubota, N. Kubodera, E. Ogata. (2006) Calcium Supplementation Does Not Reproduce the Pharmacological Efficacy of Alfacalcidol for the Treatment of Osteoporosis in Rats. Calcified Tissue International 78:3, 152-161
    CrossRef

  279. 279

    Serge Rozenberg, Daniel Murillo, Rudy Gevers, Jean Vandromme. (2006) Propensity of gynaecologists towards osteoporosis management and treatment. Maturitas 53:4, 483-488
    CrossRef

  280. 280

    Adrien Nzeusseu, Dominique Dienst, Vincent Haufroid, Geneviève Depresseux, Jean-Pierre Devogelaer, Daniel-Henri Manicourt. (2006) Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats. Bone 38:3, 394-399
    CrossRef

  281. 281

    Rebecca Hawkins. (2006) Osteoporosis. Cancer Nursing 29:Supplement, 78-82
    CrossRef

  282. 282

    Rebecca Hawkins. (2006) Osteoporosis. AJN, American Journal of Nursing 106, 78-82
    CrossRef

  283. 283

    Robin M Daly, Melanie Brown, Shona Bass, Sonja Kukuljan, Caryl Nowson. (2006) Calcium- and Vitamin D3-Fortified Milk Reduces Bone Loss at Clinically Relevant Skeletal Sites in Older Men: A 2-Year Randomized Controlled Trial. Journal of Bone and Mineral Research 21:3, 397-405
    CrossRef

  284. 284

    Carolyn Becker, Scott Crow, Jared Toman, Carter Lipton, Don J. McMahon, William Macaulay, Ethel Siris. (2006) Characteristics of elderly patients admitted to an urban tertiary care hospital with osteoporotic fractures: correlations with risk factors, fracture type, gender and ethnicity. Osteoporosis International 17:3, 410-416
    CrossRef

  285. 285

    S. Bakhtiyarova, O. Lesnyak, N. Kyznesova, M. A. Blankenstein, P. Lips. (2006) Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporosis International 17:3, 441-446
    CrossRef

  286. 286

    M. F. Holick. (2006) High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo Clinic Proceedings 81:3, 353-373
    CrossRef

  287. 287

    Finkelstein, Joel S., . (2006) Calcium plus Vitamin D for Postmenopausal Women — Bone Appétit?. New England Journal of Medicine 354:7, 750-752
    Full Text

  288. 288

    Jackson, Rebecca D., LaCroix, Andrea Z., Gass, Margery, Wallace, Robert B., Robbins, John, Lewis, Cora E., Bassford, Tamsen, Beresford, Shirley A.A., Black, Henry R., Blanchette, Patricia, Bonds, Denise E., Brunner, Robert L., Brzyski, Robert G., Caan, Bette, Cauley, Jane A., Chlebowski, Rowan T., Cummings, Steven R., Granek, Iris, Hays, Jennifer, Heiss, Gerardo, Hendrix, Susan L., Howard, Barbara V., Hsia, Judith, Hubbell, F. Allan, Johnson, Karen C., Judd, Howard, Kotchen, Jane Morley, Kuller, Lewis H., Langer, Robert D., Lasser, Norman L., Limacher, Marian C., Ludlam, Shari, Manson, JoAnn E., Margolis, Karen L., McGowan, Joan, Ockene, Judith K., O'Sullivan, Mary Jo, Phillips, Lawrence, Prentice, Ross L., Sarto, Gloria E., Stefanick, Marcia L., Van Horn, Linda, Wactawski-Wende, Jean, Whitlock, Evelyn, Anderson, Garnet L., Assaf, Annlouise R., Barad, David, . (2006) Calcium plus Vitamin D Supplementation and the Risk of Fractures. New England Journal of Medicine 354:7, 669-683
    Full Text

  289. 289

    Susan Brown. 2006. Bone Nutrition. , 443-473.
    CrossRef

  290. 290

    Michael Holick. 2006. Vitamin D. , 153-174.
    CrossRef

  291. 291

    Beverley Shea, George A Wells, Ann Cranney, Nicole Zytaruk, Lauren Griffith, Candyce Hamel, Zulma Ortiz, Joan Peterson, Peter Tugwell, Vivian Welch, Beverley Shea. 2006. Calcium supplementation on bone loss in postmenopausal women. .
    CrossRef

  292. 292

    Jean-Yves Reginster, Eric Abadie, Pierre Delmas, René Rizzoli, Willard Dere, Philippe Auwera, Bernard Avouac, Maria-Luisa Brandi, Anastasia Daifotis, Adolfo Diez-Perez, Gonzalo Calvo, Olof Johnell, Jean-Marc Kaufman, Gottfried Kreutz, Andrea Laslop, Fritz Lekkerkerker, Bruce Mitlak, Per Nilsson, John Orloff, Mary Smillie, Andrew Taylor, Yannis Tsouderos, Dominique Ethgen, Bruno Flamion. (2006) Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men. Osteoporosis International 17:1, 1-7
    CrossRef

  293. 293

    Eric J MacLaughlin, Rebecca B Sleeper, Danny McNatty, Cynthia L Raehl. (2006) Management of age-related osteoporosis and prevention of associated fractures. Therapeutics and Clinical Risk Management 2:3, 281-295
    CrossRef

  294. 294

    Jennie L Wells, Andrea C Dumbrell. (2006) Nutrition and aging: assessment and treatment of compromised nutritional status in frail elderly patients. Clinical Interventions in Aging 1:1, 67-79
    CrossRef

  295. 295

    Daniel Albertsson, Ingrid Gause-Nilsson, Dan Mellström, Robert Eggertsen. (2006) Risk Group for Hip Fracture in Elderly Women Identified by Primary Care Questionnaire - Clinical Implications. Upsala Journal of Medical Sciences 111:2, 179-188
    CrossRef

  296. 296

    Robert P Heaney. (2006) Alendronate plus cholecalciferol for the treatment of osteoporosis. Women's Health 2:1, 23-27
    CrossRef

  297. 297

    Johann D Ringe, Stefan A P van der Geest, Gerd M??ller. (2006) Importance of Calcium Co-Medication in Bisphosphonate Therapy of Osteoporosis. Drugs & Aging 23:7, 569-578
    CrossRef

  298. 298

    Marco Di Monaco, Fulvia Vallero, Roberto Di Monaco, Rosa Tappero, Alberto Cavanna. (2005) 25-Hydroxyvitamin D, parathyroid hormone, and functional recovery after hip fracture in elderly patients. Journal of Bone and Mineral Metabolism 24:1, 42-47
    CrossRef

  299. 299

    C. F. Garland. (2005) The Role of Vitamin D in Cancer Prevention. American Journal of Public Health 96:2, 252-261
    CrossRef

  300. 300

    Heike A. Bischoff-Ferrari, Yuqing Zhang, Douglas P. Kiel, David T. Felson. (2005) Positive association between serum 25-hydroxyvitamin D level and bone density in osteoarthritis. Arthritis & Rheumatism 53:6, 821-826
    CrossRef

  301. 301

    Yoshihiro Sato, Yoshiaki Honda, Jun Iwamoto, Tomohiro Kanoko, Kei Satoh. (2005) Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients. Movement Disorders 20:12, 1598-1603
    CrossRef

  302. 302

    Heike A Bischoff-Ferrari. (2005) Extra-skeletal effects of vitamin D. Current Opinion in Endocrinology & Diabetes 12:6, 464-470
    CrossRef

  303. 303

    Matthew R Smith. (2005) Therapy Insight: osteoporosis during hormone therapy for prostate cancer. Nature Clinical Practice Urology 2:12, 608-615
    CrossRef

  304. 304

    Jenny A. Lucas, Mark J. Bolland, Andrew B. Grey, Ruth W. Ames, Barbara H. Mason, Anne M. Horne, Greg D. Gamble, Ian R. Reid. (2005) Determinants of vitamin D status in older women living in a subtropical climate. Osteoporosis International 16:12, 1641-1648
    CrossRef

  305. 305

    Michel Brazier, Franck Grados, Saïd Kamel, Marc Mathieu, Alain Morel, Mohamed Maamer, Jean-Luc Sebert, Patrice Fardellone. (2005) Clinical and laboratory safety of one year's use of acombination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: Results of a mlticenter, rndomized, double-blind, placebo-controlled study. Clinical Therapeutics 27:12, 1885-1893
    CrossRef

  306. 306

    M. Teresa del Campo, Pilar Aguado, M. Eugenia Martínez. (2005) Vitamina D y salud ósea: ¿es necesario revisar la administración de sus suplementos en poblaciones de riesgo de osteoporosis?. Medicina Clínica 125:20, 788-793
    CrossRef

  307. 307

    M. F. Hitz, P. C. Eskildsen, J. B. Jensen. (2005) Bioavailability of Calcium: Comparison of Calcium Carbonate and Milk and the Effect of Vitamin D, Age, and Sex Using 24-Hour Urine Calcium as a Method. Calcified Tissue International 77:6, 361-366
    CrossRef

  308. 308

    Denise G. Mühlen, Gail A. Greendale, Cedric F. Garland, Lori Wan, Elizabeth Barrett-Connor. (2005) Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: The Rancho Bernardo Study. Osteoporosis International 16:12, 1721-1726
    CrossRef

  309. 309

    Kevin D. Cashman. (2005) Functional foods and bone health. Food Science <html_ent glyph="@amp;" ascii="&"/> Technology Bulletin: Functional Foods 2:6, 59-69
    CrossRef

  310. 310

    Leon Flicker, Robert J. MacInnis, Mark S. Stein, Sam C. Scherer, Kate E. Mead, Caryl A. Nowson, Jenny Thomas, Chris Lowndes, John L. Hopper, John D. Wark. (2005) Should Older People in Residential Care Receive Vitamin D to Prevent Falls? Results of a Randomized Trial. Journal of the American Geriatrics Society 53:11, 1881-1888
    CrossRef

  311. 311

    Pekka Kannus, Harri Sievänen, Mika Palvanen, Teppo Järvinen, Jari Parkkari. (2005) Prevention of falls and consequent injuries in elderly people. The Lancet 366:9500, 1885-1893
    CrossRef

  312. 312

    Robert P. Heaney, Ruth Carey, Laura Harkness. (2005) Roles of Vitamin D, n-3 Polyunsaturated Fatty Acid, and Soy Isoflavones in Bone Health. Journal of the American Dietetic Association 105:11, 1700-1702
    CrossRef

  313. 313

    P. Gerdhem, K. A. M. Ringsberg, K. J. Obrant, K. Akesson. (2005) Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporosis International 16:11, 1425-1431
    CrossRef

  314. 314

    Laura D. Carbone, Karen D. Barrow, Andrew J. Bush, M. David Boatright, Jean A. Michelson, Kathleen A. Pitts, Victorina N. Pintea, Andrew H. Kang, Mitchell A. Watsky. (2005) Effects of a low sodium diet on bone metabolism. Journal of Bone and Mineral Metabolism 23:6, 506-513
    CrossRef

  315. 315

    Wojciech P Olszynski, K Shawn Davison. (2005) Osteoporosis in men: the quieter half of a silent disease. Aging Health 1:2, 263-272
    CrossRef

  316. 316

    Ronald C. Hamdy, Charles H. Chesnut, Margery L. Gass, Michael F. Holick, Edward S. Leib, Michael E. Lewiecki, Michael Maricic, Nelson B. Watts. (2005) Review of Treatment Modalities for Postmenopausal Osteoporosis. Southern Medical Journal 98:10, 1000-1014
    CrossRef

  317. 317

    Roland Staud. (2005) Vitamin D: More than just affecting calcium and bone. Current Rheumatology Reports 7:5, 356-364
    CrossRef

  318. 318

    Charles F. Hildebolt. (2005) Effect of Vitamin D and Calcium on Periodontitis. Journal of Periodontology 76:9, 1576-1587
    CrossRef

  319. 319

    J-P-H. Bonjour, T. Chevalley, S. Ferrari, R. Rizzoli. (2005) Lait et santé osseuse : rôle essentiel du calcium et des protéines. Cahiers de Nutrition et de Diététique 40, 12-19
    CrossRef

  320. 320

    A.W. Murray, C. McQuillan, B. Kennon, S.J. Gallacher. (2005) Osteoporosis risk assessment and treatment intervention after hip or shoulder fracture. Injury 36:9, 1080-1084
    CrossRef

  321. 321

    Rosen, Clifford J., . (2005) Postmenopausal Osteoporosis. New England Journal of Medicine 353:6, 595-603
    Full Text

  322. 322

    Yoshihiro Sato, Jun Iwamoto, Tomohiro Kanoko, Kei Satoh. (2005) Amelioration of Osteoporosis and Hypovitaminosis D by Sunlight Exposure in Hospitalized, Elderly Women With Alzheimer's Disease: A Randomized Controlled Trial. Journal of Bone and Mineral Research 20:8, 1327-1333
    CrossRef

  323. 323

    Adrianne C. Feldstein, Gregory Nichols, Eric Orwoll, Patricia J. Elmer, David H. Smith, Michael Herson, Mikel Aickin. (2005) The near absence of osteoporosis treatment in older men with fractures. Osteoporosis International 16:8, 953-962
    CrossRef

  324. 324

    Anders Halling, G. Rutger Persson, Johan Berglund, Owe Johansson, Stefan Renvert. (2005) Comparison between the Klemetti index and heel DXA BMD measurements in the diagnosis of reduced skeletal bone mineral density in the elderly. Osteoporosis International 16:8, 999-1003
    CrossRef

  325. 325

    Catherine Van Poznak, Nicholas P. Sauter. (2005) Clinical management of osteoporosis in women with a history of breast carcinoma. Cancer 104:3, 443-456
    CrossRef

  326. 326

    Alison Avenell, William J Gillespie, Lesley D Gillespie, Dianne O'Connell, Alison Avenell. 2005. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. .
    CrossRef

  327. 327

    L. Carreño Pérez. (2005) Tratamiento de la pérdida de masa ósea en la mujer postmenopáusica. Revista Clínica Española 205:7, 341-351
    CrossRef

  328. 328

    Christine Simonelli, Thomas W. Weiss, Julie Morancey, Leah Swanson, Ya-Ting Chen. (2005) Prevalence of vitamin D inadequacy in a minimal trauma fracture population*. Current Medical Research and Opinion 21:7, 1069-1074
    CrossRef

  329. 329

    John A. Kanis, Helena Johansson, Anders Oden, Chris Laet, Olof Johnell, John A. Eisman, Eugene McCloskey, Dan Mellstrom, Huibert Pols, Jonathan Reeve, Alan Silman, Alan Tenenhouse. (2005) A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporosis International 16:7, 799-804
    CrossRef

  330. 330

    Bess Dawson-Hughes, Robert P. Heaney, Michael F. Holick, Paul Lips, Pierre J. Meunier, Reinhold Vieth. (2005) Estimates of optimal vitamin D status. Osteoporosis International 16:7, 713-716
    CrossRef

  331. 331

    S. L. Greenspan, N. M. Resnick, R. A. Parker. (2005) Vitamin D Supplementation in Older Women. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:6, 754-759
    CrossRef

  332. 332

    Sara A. Quandt, John G. Spangler, L. Douglas Case, Ronny A. Bell, Amy E. Belflower. (2005) Smokeless tobacco use accelerates age-related loss of bone mineral density among older women in a multi-ethnic rural community. Journal of Cross-Cultural Gerontology 20:2, 109-125
    CrossRef

  333. 333

    Serge L. Ferrari, R. Rizzoli. (2005) Gene variants for osteoporosis and their pleiotropic effects in aging. Molecular Aspects of Medicine 26:3, 145-167
    CrossRef

  334. 334

    Manuel Montero-Odasso, Gustavo Duque. (2005) Vitamin D in the aging musculoskeletal system: An authentic strength preserving hormone. Molecular Aspects of Medicine 26:3, 203-219
    CrossRef

  335. 335

    Ghada El-Hajj Fuleihan, Rafic Baddoura, Hassane Awada, Jad Okais, Paul Rizk, Michael McClung. (2005) Lebanese Guidelines for Osteoporosis Assessment and Treatment. Journal of Clinical Densitometry 8:2, 148-163
    CrossRef

  336. 336

    M. Peterlik, H. S. Cross. (2005) Vitamin D and calcium deficits predispose for multiple chronic diseases. European Journal of Clinical Investigation 35:5, 290-304
    CrossRef

  337. 337

    Philip Sambrook. (2005) Vitamin D and fractures: quo vadis?. The Lancet 365:9471, 1599-1600
    CrossRef

  338. 338

    T. Vogel, T. Dobler, H. Bitterling, P. Biberthaler, K.-G. Kanz, K.-J. Pfeifer, R. Bartl, W. Mutschler. (2005) Osteoporose in der Unfallchirurgie. Der Unfallchirurg 108:5, 356-364
    CrossRef

  339. 339

    (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. The Lancet 365:9471, 1621-1628
    CrossRef

  340. 340

    Charles N Bernstein, William D Leslie. (2005) Therapy Insight: osteoporosis in inflammatory bowel disease—advances and retreats. Nature Clinical Practice Gastroenterology &#38; Hepatology 2:5, 232-239
    CrossRef

  341. 341

    Ergin Serhan, Martin R. Holland. (2005) Calcium and vitamin D supplementation failed to improve bone mineral density in Indo-Asians suffering from hypovitaminosis D and secondary hyperparathyroidism. Rheumatology International 25:4, 276-279
    CrossRef

  342. 342

    Pilar García-Lorda, Jordi Salas-Salvadó, José María Cobo. (2005) Ingesta de calcio y obesidad. Medicina Clínica 124:12, 467-475
    CrossRef

  343. 343

    C. V. Harinarayan. (2005) Prevalence of vitamin D insufficiency in postmenopausal south Indian women. Osteoporosis International 16:4, 397-402
    CrossRef

  344. 344

    Hosam K. Kamel. (2005) Secondary Prevention of Hip Fractures Among the Hospitalized Elderly. JCR: Journal of Clinical Rheumatology 11:2, 68-71
    CrossRef

  345. 345

    Véronique Coxam. (2005) Inulin-type fructans and bone health: state of the art and perspectives in the management of osteoporosis. British Journal of Nutrition 93:S1, S111
    CrossRef

  346. 346

    Jean-Yves Reginster. (2005) The high prevalence of inadequate serum vitamin D levels and implications for bone health. Current Medical Research and Opinion 21:4, 579-585
    CrossRef

  347. 347

    Steven Boonen, Jean-Jacques Body, Yves Boutsen, Jean-Pierre Devogelaer, Stefan Goemaere, Jean-Marc Kaufman, Serge Rozenberg, Jean-Yves Reginster. (2005) Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporosis International 16:3, 239-254
    CrossRef

  348. 348

    Leif Mosekilde. (2005) Vitamin D and the elderly. Clinical Endocrinology 62:3, 265-281
    CrossRef

  349. 349

    Astrid Fahrleitner-Pammer, Andrea Obernosterer, Ernst Pilger, Harald Dobnig, Hans Peter Dimai, Georg Leb, Stefan Kudlacek, Barbara M. Obermayer-Pietsch. (2005) Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporosis International 16:3, 319-324
    CrossRef

  350. 350

    Jose Ness, Wilbert S Aronow, Erin Newkirk, Deanna McDanel. (2005) Underutilization of Calcium and Vitamin D by Older Adults in a Large General Internal Medicine Practice. American Journal of Therapeutics 12:2, 113-116
    CrossRef

  351. 351

    F. Richy, E. Schacht, O. Bruyere, O. Ethgen, M. Gourlay, J.-Y. Reginster. (2005) Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis. Calcified Tissue International 76:3, 176-186
    CrossRef

  352. 352

    Redonda G. Miller, Katherine C. Chretien, Lucy A. Meoni, Ya-Pei Liu, Michael J. Klag, Michael A. Levine. (2005) Comparison of Intravenous Pamidronate to Standard Therapy for Osteoporosis. JCR: Journal of Clinical Rheumatology 11:1, 2-7
    CrossRef

  353. 353

    Yoshihiro Sato, Jun Iwamoto, Tomohiro Kanoko, Kei Satoh. (2005) Low-Dose Vitamin D Prevents Muscular Atrophy and Reduces Falls and Hip Fractures in Women after Stroke: A Randomized Controlled Trial. Cerebrovascular Diseases 20:3, 187-192
    CrossRef

  354. 354

    Marco Di Monaco, Fulvia Vallero, Roberto Di Monaco, Fulvio Mautino, Alberto Cavanna. (2005) Serum levels of 25-Hydroxyvitamin D and functional recovery after hip fracture. Archives of Physical Medicine and Rehabilitation 86:1, 64-68
    CrossRef

  355. 355

    Hosam K Kamel. (2005) Male Osteoporosis. Drugs & Aging 22:9, 741-748
    CrossRef

  356. 356

    K Martin Wissing, Nilufer Broeders, Rodrigo Moreno-Reyes, Christine Gervy, Bernard Stallenberg, Daniel Abramowicz. (2005) A Controlled Study of Vitamin D3 to Prevent Bone Loss in Renal-Transplant Patients Receiving Low Doses of Steroids. Transplantation 79:1, 108-115
    CrossRef

  357. 357

    Mark A. Moyad. (2005) An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part I. Urologic Oncology: Seminars and Original Investigations 23:1, 28-35
    CrossRef

  358. 358

    Agostino Gaudio, Nancy Morabito. (2005) Pharmacological Management of Severe Postmenopausal Osteoporosis. Drugs & Aging 22:5, 405-417
    CrossRef

  359. 359

    Terrence H Diamond. (2005) Pharmacotherapy of osteoporosis in men. Expert Opinion on Pharmacotherapy 6:1, 45-58
    CrossRef

  360. 360

    Yoshihiro Sato, Tomohiro Kanoko, Kei Satoh, Jun Iwamoto. (2005) Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone 36:1, 61-68
    CrossRef

  361. 361

    Peter Vestergaard. (2005) Antiresorptive Therapy for the Prevention of Postmenopausal Osteoporosis. Treatments in Endocrinology 4:5, 263-277
    CrossRef

  362. 362

    Mark A. Moyad. (2005) An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part II. Urologic Oncology: Seminars and Original Investigations 23:1, 36-48
    CrossRef

  363. 363

    Julian R Molina, Debra L Barton, Charles L Loprinzi. (2005) Chemotherapy-Induced Ovarian Failure. Drug Safety 28:5, 401-416
    CrossRef

  364. 364

    D BAE, B STEIN. (2004) THE DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS IN MEN ON ANDROGEN DEPRIVATION THERAPY FOR ADVANCED CARCINOMA OF THE PROSTATE. The Journal of Urology 172:6, 2137-2144
    CrossRef

  365. 365

    Faryal S. Mirza, Karen M. Prestwood. (2004) Bone health and aging: implications for menopause. Endocrinology & Metabolism Clinics of North America 33:4, 741-759
    CrossRef

  366. 366

    Goonaseelan Pillai, Ronald Gieschke, Timothy Goggin, Philippe Jacqmin, Ralph C. Schimmer, Jean-Louis Steimer. (2004) A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis. British Journal of Clinical Pharmacology 58:6, 618-631
    CrossRef

  367. 367

    Celestia Higano, Andrew Shields, Nathanael Wood, Judy Brown, Cathy Tangen. (2004) Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression. Urology 64:6, 1182-1186
    CrossRef

  368. 368

    John Eisman, Sharon Clapham, Linda Kehoe. (2004) Osteoporosis Prevalence and Levels of Treatment in Primary Care: The Australian BoneCare Study. Journal of Bone and Mineral Research 19:12, 1969-1975
    CrossRef

  369. 369

    C. Roux. (2004) Ostéoporose postménopausique : les traitements actuels. La Revue de Médecine Interne 25, S568-S572
    CrossRef

  370. 370

    H. Blain. (2004) L'ostéoporose masculine: épidémiologie, physiopathologie, diagnostic, prévention et traitement. La Revue de Médecine Interne 25, S552-S559
    CrossRef

  371. 371

    Nalini Sharma, Bradley Trope, Timothy O. Lipman. (2004) Vitamin Supplementation. Journal of Clinical Gastroenterology 38:10, 844-854
    CrossRef

  372. 372

    Kenneth W. Lyles, Cathleen Colón-Emeric. (2004) Treating Vitamin D Deficiency in Long-Term Care: It Should Be Done Yesterday, But How?. Journal of the American Medical Directors Association 5:6, 416-417
    CrossRef

  373. 373

    Paul J. Drinka. (2004) The Importance of Parathyroid Hormone and Vitamin D Status in the Treatment of Osteoporosis and Renal Insufficiency. Journal of the American Medical Directors Association 5:6, 382-386
    CrossRef

  374. 374

    MATTHEW R. SMITH. (2004) OSTEOPOROSIS AND OBESITY IN MEN RECEIVING HORMONE THERAPY FOR PROSTATE CANCER. The Journal of Urology 172:5, S52-S57
    CrossRef

  375. 375

    Mark Messina, Suzanne Ho, D Lee Alekel. (2004) Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data. Current Opinion in Clinical Nutrition and Metabolic Care 7:6, 649-658
    CrossRef

  376. 376

    Matthew R. Smith. (2004) Osteoclast-targeted therapy for prostate cancer. Current Treatment Options in Oncology 5:5, 367-375
    CrossRef

  377. 377

    Jeri W Nieves. (2004) Calcium and vitamin D: current developments in the prevention of osteoporosis and osteomalacia. Current Opinion in Orthopaedics 15:5, 383-388
    CrossRef

  378. 378

    2004. Calcium. .
    CrossRef

  379. 379

    Stuart L. Silverman, Pierre D. Delmas, Pandurang M. Kulkarni, John L. Stock, Mayme Wong, Leo Plouffe. (2004) Comparison of Fracture, Cardiovascular Event, and Breast Cancer Rates at 3 Years in Postmenopausal Women with Osteoporosis. Journal of the American Geriatrics Society 52:9, 1543-1548
    CrossRef

  380. 380

    KHASHAYAR SAKHAEE, JOHN R. POINDEXTER, CAROLYN S. GRIFFITH, CHARLES Y.C. PAK. (2004) STONE FORMING RISK OF CALCIUM CITRATE SUPPLEMENTATION IN HEALTHY POSTMENOPAUSAL WOMEN. The Journal of Urology 172:3, 958-961
    CrossRef

  381. 381

    Gladys Barrera, Daniel Bunout, Vivien Gattás, María Pía de la Maza, Laura Leiva, Sandra Hirsch. (2004) A high body mass index protects against femoral neck osteoporosis in healthy elderly subjects. Nutrition 20:9, 769-771
    CrossRef

  382. 382

    Laura L. Tosi, Mary L. Bouxsein, Olof Johnell. (2004) Commentary on the AAOS Position Statement: Recommendations for Enhancing the Care of Patients with Fragility Fractures. Techniques in Orthopaedics 19:3, 121-125
    CrossRef

  383. 383

    Brigitte L. Sicat. (2004) Should Postmenopausal Hormone Therapy Be Used to Prevent Osteoporosis?. The Consultant Pharmacist 19:8, 725-735
    CrossRef

  384. 384

    Jane F Potter. (2004) The Older Orthopaedic Patient. Clinical Orthopaedics and Related Research 425, 44-49
    CrossRef

  385. 385

    Christian Meier, Henning W Woitge, Klaus Witte, Björn Lemmer, Markus J Seibel. (2004) Supplementation With Oral Vitamin D3 and Calcium During Winter Prevents Seasonal Bone Loss: A Randomized Controlled Open-Label Prospective Trial. Journal of Bone and Mineral Research 19:8, 1221-1230
    CrossRef

  386. 386

    S. Y. Wong, E. M. Lau, W. W. Lau, H. S. Lynn. (2004) Is dietary counselling effective in increasing dietary calcium, protein and energy intake in patients with osteoporotic fractures? A randomized controlled clinical trial. Journal of Human Nutrition and Dietetics 17:4, 359-364
    CrossRef

  387. 387

    H KAMEL, R HAJJAR. (2004) Osteoporosis for the Home Care Physician Part 2: Management. Journal of the American Medical Directors Association 5:4, 259-262
    CrossRef

  388. 388

    Bruce Kessel. (2004) Hip Fracture Prevention in Postmenopausal Women. Obstetrical & Gynecological Survey 59:6, 446-455
    CrossRef

  389. 389

    Michele M. Gottschlich, Theresa Mayes, Jane Khoury, Glenn D. Warden. (2004) Hypovitaminosis D in acutely injured pediatric burn patients. Journal of the American Dietetic Association 104:6, 931-941
    CrossRef

  390. 390

    Charles F. Hildebolt, Thomas K. Pilgram, Mary Dotson, Reina Armamento-Villareal, Jay Hauser, Sheldon Cohen, Roberto Civitelli. (2004) Estrogen and/or Calcium Plus Vitamin D Increase Mandibular Bone Mass. Journal of Periodontology 75:6, 811-816
    CrossRef

  391. 391

    C. N. Bernstein, W. D. Leslie. (2004) Osteoporosis and inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 19:9, 941-952
    CrossRef

  392. 392

    Reinhold Vieth. (2004) Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. The Journal of Steroid Biochemistry and Molecular Biology 89-90, 575-579
    CrossRef

  393. 393

    Julie A Pasco, Margaret J Henry, Mark A Kotowicz, Kerrie M Sanders, Ego Seeman, John R Pasco, Hans G Schneider, Geoffrey C Nicholson. (2004) Seasonal Periodicity of Serum Vitamin D and Parathyroid Hormone, Bone Resorption, and Fractures: The Geelong Osteoporosis Study. Journal of Bone and Mineral Research 19:5, 752-758
    CrossRef

  394. 394

    J.C. Gallagher. (2004) The effects of calcitriol on falls and fractures and physical performance tests. The Journal of Steroid Biochemistry and Molecular Biology 89-90, 497-501
    CrossRef

  395. 395

    Paul Lips. (2004) Which circulating level of 25-hydroxyvitamin D is appropriate?. The Journal of Steroid Biochemistry and Molecular Biology 89-90, 611-614
    CrossRef

  396. 396

    Haakon E. Meyer. (2004) Calcium and osteoporotic fractures. British Journal of Nutrition 91:04, 505
    CrossRef

  397. 397

    Rachael L. Fleurence. (2004) Cost-effectiveness of fracture prevention treatments in the elderly. International Journal of Technology Assessment in Health Care 20:02,
    CrossRef

  398. 398

    Rebecca Costello, Judith Finkelstein, Leila Saldanha, Michelle Dell'Orto. (2004) Executive Summary: Conference on Dietary Supplement Use in the Elderly - Proceedings of the Conference Held January 14-15, 2003, Natcher Auditorium, National Institutes of Health, Bethesda, MD. Nutrition Reviews 62:4, 160-175
    CrossRef

  399. 399

    Serge L Ferrari, David Karasik, Jun Liu, Samev Karamohamed, Alan G Herbert, L Adrienne Cupples, Douglas P Kiel. (2004) Interactions of Interleukin-6 Promoter Polymorphisms With Dietary and Lifestyle Factors and Their Association With Bone Mass in Men and Women From the Framingham Osteoporosis Study. Journal of Bone and Mineral Research 19:4, 552-559
    CrossRef

  400. 400

    Hosam K. Kamel, Hot Springs, Adriana Bida, Marcos Montagnini. (2004) Secondary Prevention of Hip Fractures in Veterans: Can We Do Better?. Journal of the American Geriatrics Society 52:4, 647-648
    CrossRef

  401. 401

    A López-Caudana. (2004) Predictors of bone mineral density in female workers in Morelos state, Mexico. Archives of Medical Research 35:2, 172-180
    CrossRef

  402. 402

    Erik Roj Larsen, Leif Mosekilde, Anders Foldspang. (2004) Vitamin D and Calcium Supplementation Prevents Osteoporotic Fractures in Elderly Community Dwelling Residents: A Pragmatic Population-Based 3-Year Intervention Study. Journal of Bone and Mineral Research 19:3, 370-378
    CrossRef

  403. 403

    Elena Segal, Haim Zinnman, Batia Raz, Ada Tamir, Sophia Ish-Shalom. (2004) Adherence to Vitamin D Supplementation in Elderly Patients After Hip Fracture. Journal of the American Geriatrics Society 52:3, 474-475
    CrossRef

  404. 404

    Nelson B. Watts. (2004) Is it ethical to use placebos in osteoporosis clinical trials?. Current Osteoporosis Reports 2:1, 31-36
    CrossRef

  405. 405

    A. I. Sidwell, T. J. Wilkinson, H. C. Hanger. (2004) Secondary prevention of fractures in older people: evaluation of a protocol for the investigation and treatment of osteoporosis. Internal Medicine Journal 34:3, 129-132
    CrossRef

  406. 406

    Hosam K. Kamel. (2004) Underutilization of Calcium and Vitamin D Supplements in an Academic Long-Term Care Facility. Journal of the American Medical Directors Association 5:2, 98-100
    CrossRef

  407. 407

    Susanna Hii, Sam Scherer. (2004) Vitamin D deficiency and secondary hyperparathyroidism in older people with low trauma fractures. Australasian Journal on Ageing 23:1, 45-47
    CrossRef

  408. 408

    Susan A. New, Roger M. Francis. (2004) Understanding, Preventing and Overcoming Osteoporosis. Nutrition Bulletin 29:1, 70-71
    CrossRef

  409. 409

    HA Bischoff-Ferrari, M Borchers, F Gudat, U Dürmüller, HB Stähelin, W Dick. (2004) Vitamin D Receptor Expression in Human Muscle Tissue Decreases With Age. Journal of Bone and Mineral Research 19:2, 265-269
    CrossRef

  410. 410

    A Prentice. (2004) Diet, nutrition and the prevention of osteoporosis. Public Health Nutrition 7:1a,
    CrossRef

  411. 411

    R.M. Francis. (2004) Acute and long-term management of patients with vertebral fractures. QJM 97:2, 63-74
    CrossRef

  412. 412

    BJ Shea, JD Adachi, A Cranney, L Griffith, G Guyatt, C Hamel, Z Ortiz, J Peterson, VA Robinson, P Tugwell, G Wells, N Zytaruk, Beverley Shea. 2004. Calcium supplementation on bone loss in postmenopausal women. .
    CrossRef

  413. 413

    Wojciech P. Olszynski, K. Shawn Davison, Jonathan D. Adachi, Jacques P. Brown, Steven R. Cummings, David A. Hanley, Steven P. Harris, Anthony B. Hodsman, David Kendler, Michael R. McClung, Paul D. Miller, Chui Kin Yuen. (2004) Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment. Clinical Therapeutics 26:1, 15-28
    CrossRef

  414. 414

    Nelson B. Watts. (2004) Is it ethical to use placebos in osteoporosis clinical trials?. Current Rheumatology Reports 6:1, 79-84
    CrossRef

  415. 415

    L. Ovesen. 2004. Vitamin D fortification and bone health. , 139-173.
    CrossRef

  416. 416

    Ian R Reid. (2004) Effects of Calcium Supplementation on Circulating Lipids. Drugs & Aging 21:1, 7-17
    CrossRef

  417. 417

    William D Fraser. (2004) The Burden of Osteoporosis and the Case for Disease Management. Disease Management & Health Outcomes 12:6, 409-418
    CrossRef

  418. 418

    H. H. Bolotin. (2004) The significant effects of bone structure on inherent patient-specific DXA in vivo bone mineral density measurement inaccuracies. Medical Physics 31:4, 774
    CrossRef

  419. 419

    K. D. Cashman. 2004. Diet and the control of osteoporosis. , 83-114.
    CrossRef

  420. 420

    Peter R Ebeling. (2004) Idiopathic or Hypogonadal Osteoporosis in Men. Treatments in Endocrinology 3:6, 381-391
    CrossRef

  421. 421

    CELESTIA S. HIGANO. (2003) Management of Bone Loss in Men With Prostate Cancer. The Journal of Urology 170:6, S59-S64
    CrossRef

  422. 422

    Anne M. Kenny, Bradley Biskup, Bertha Robbins, Glenn Marcella, Joseph A. Burleson. (2003) Effects of Vitamin D Supplementation on Strength, Physical Function, and Health Perception in Older, Community-Dwelling Men. Journal of the American Geriatrics Society 51:12, 1762-1767
    CrossRef

  423. 423

    D. Sudhaker Rao, Suhad Alqurashi. (2003) Management of vitamin D depletion in postmenopausal women. Current Osteoporosis Reports 1:3, 110-115
    CrossRef

  424. 424

    Xavier Deprez, Patrice Fardellone. (2003) Nonpharmacological prevention of osteoporotic fractures. Joint Bone Spine 70:6, 448-457
    CrossRef

  425. 425

    G. A. Plotnikoff, J. M. Quigley. (2003) Prevalence of Severe Hypovitaminosis D in Patients With Persistent, Nonspecific Musculoskeletal Pain. Mayo Clinic Proceedings 78:12, 1463-1470
    CrossRef

  426. 426

    Albert Flynn. (2003) The role of dietary calcium in bone health. Proceedings of the Nutrition Society 62:04, 851-858
    CrossRef

  427. 427

    Jack W. Coburn. (2003) An update on vitamin D as related to nephrology practice: 2003. Kidney International 64:s87, 125-130
    CrossRef

  428. 428

    Lesley D Gillespie, William J Gillespie, M Clare Robertson, Sarah E Lamb, Robert G Cumming, Brian H Rowe, Lesley D Gillespie. 2003. Interventions for preventing falls in elderly people. .
    CrossRef

  429. 429

    Pearl L Breitman, Debbie Fonseca, Angela M Cheung, Wendy E Ward. (2003) Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone. Bone 33:4, 597-605
    CrossRef

  430. 430

    Rebecca D Jackson, Andrea Z Lacroix, Jane A Cauley, Joan Mcgowan. (2003) The women's health initiative calcium–vitamin D trial: overview and baseline characteristics of participants. Annals of Epidemiology 13:9, S98-S106
    CrossRef

  431. 431

    C. Broadhurst, K. C. M. Wilson, M. T. Kinirons, A. Wagg, J. K. Dhesi. (2003) Clinical pharmacology of old age syndromes. British Journal of Clinical Pharmacology 56:3, 261-272
    CrossRef

  432. 432

    Lois E. Wehren, Jay Magaziner. (2003) Hip fracture: Risk factors and outcomes. Current Osteoporosis Reports 1:2, 78-85
    CrossRef

  433. 433

    Yasuko Sekine, Naomi Matsunaga, Akatsuki Kokaze, Masao Yoshida, Kenji Suzuki, Hideki Ohno, Yutaka Takashima. (2003) Effects of Nutrient and Food Intake on Calcaneous Bone Mass among Healthy Japanese Women in the Predelivery and Postpartum Periods. Journal of Women's Health 12:7, 643-654
    CrossRef

  434. 434

    Nancy K. Latham, Craig S. Anderson, Ian R. Reid. (2003) Effects of Vitamin D Supplementation on Strength, Physical Performance, and Falls in Older Persons: A Systematic Review. Journal of the American Geriatrics Society 51:9, 1219-1226
    CrossRef

  435. 435

    Mark A Moyad. (2003) The potential benefits of dietary and/or supplemental calcium and vitamin D. Urologic Oncology: Seminars and Original Investigations 21:5, 384-391
    CrossRef

  436. 436

    Francisco A Conde, William J Aronson. (2003) Risk factors for male osteoporosis. Urologic Oncology: Seminars and Original Investigations 21:5, 380-383
    CrossRef

  437. 437

    John Anderson. 2003. Diet and Osteoporosis. , 243-255.
    CrossRef

  438. 438

    Julian RF Walters. (2003) The role of the intestine in bone homeostasis. European Journal of Gastroenterology & Hepatology 15:8, 845-849
    CrossRef

  439. 439

    AJ Schou, C Heuck, OD Wolthers. (2003) Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover. Acta Paediatrica 92:7, 797-801
    CrossRef

  440. 440

    Baruch A Brody, Nancy Dickey, Susan S Ellenberg, Robert P Heaney, Robert J Levine, Richard L O'brien, Ruth B Purtilo, Charles Weijer. (2003) Is the Use of Placebo Controls Ethically Permissible in Clinical Trials of Agents Intended to Reduce Fractures in Osteoporosis?. Journal of Bone and Mineral Research 18:6, 1105-1109
    CrossRef

  441. 441

    Kelly A. Mcgary, Dominick Tammaro, Michele G. Cyr. (2003) Diagnosing and managing post menopausal osteoporosis: Opportunities for fracture prevention. Comprehensive Therapy 29:2-3, 115-123
    CrossRef

  442. 442

    Franck Grados, Michel Brazier, Saïd Kamel, Sigolène Duver, Nathalie Heurtebize, Mohamed Maamer, Marc Mathieu, Michèle Garabédian, Jean-Luc Sebert, Patrice Fardellone. (2003) Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency. Joint Bone Spine 70:3, 203-208
    CrossRef

  443. 443

    Pawel Szulc, Pierre Jean Meunier. (2003) Synergistic effect of vitamin D and calcium in preventing proximal femoral fractures in older patients. Joint Bone Spine 70:3, 157-160
    CrossRef

  444. 444

    Jennifer White, Susan S. Harris, Gerard E. Dallal, Bess Dawson-Hughes. (2003) Precision of Single vs Bilateral Hip Bone Mineral Density Scans. Journal of Clinical Densitometry 6:2, 159-162
    CrossRef

  445. 445

    James M. Gill, Matthew K. Hoffman. (2003) Prevention and Treatment of Osteoporosis in Primary Care Offices. Journal of Women's Health 12:5, 473-480
    CrossRef

  446. 446

    Matthew R Smith. (2003) Management of treatment-related osteoporosis in men with prostate cancer. Cancer Treatment Reviews 29:3, 211-218
    CrossRef

  447. 447

    MATTHEW R. SMITH, JAMES EASTHAM, DONALD M. GLEASON, DANIEL SHASHA, SIMON TCHEKMEDYIAN, NORMAN ZINNER. (2003) Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer. The Journal of Urology 169:6, 2008-2012
    CrossRef

  448. 448

    Karl Michaëlsson, Håkan Melhus, Rino Bellocco, Alicja Wolk. (2003) Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. Bone 32:6, 694-703
    CrossRef

  449. 449

    Bess Dawson-Hughes. (2003) Calcium and protein in bone health. Proceedings of the Nutrition Society 62:02, 505-509
    CrossRef

  450. 450

    Armin Zittermann. (2003) Vitamin D in preventive medicine: are we ignoring the evidence?. British Journal of Nutrition 89:05, 552
    CrossRef

  451. 451

    Joyce K. Stechmiller. (2003) Early Nutritional Screening of Older Adults. Journal of Infusion Nursing 26:3, 170-177
    CrossRef

  452. 452

    Nancy A Dawson. (2003) Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease. Expert Opinion on Pharmacotherapy 4:5, 705-716
    CrossRef

  453. 453

    Hervé Lilliu, Raymond Pamphile, Marie-Claire Chapuy, Jeltje Schulten, Monique Arlot, Pierre J. Meunier. (2003) Calcium–vitamin D3 supplementation is cost-effective in hip fractures prevention. Maturitas 44:4, 299-305
    CrossRef

  454. 454

    L.Joseph Melton, Robert P. Heaney. (2003) Too much medicine? or too little?. Bone 32:4, 327-331
    CrossRef

  455. 455

    Robert P Heaney, Connie M Weaver. (2003) Calcium and vitamin D. Endocrinology & Metabolism Clinics of North America 32:1, 181-194
    CrossRef

  456. 456

    Mark A. Moyad. (2003) The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy. Part II - rapid review of dietary supplements. Current Opinion in Urology 13:2, 147-151
    CrossRef

  457. 457

    Rick L. Smith. (2003) Calcium and Vitamin D Supplementation in Nursing Home Residents. Journal of the American Medical Directors Association 4:2, S24-S31
    CrossRef

  458. 458

    David H. Alpers. (2003) Vitamin therapy for metabolic diseases. Current Opinion in Gastroenterology 19:2, 130-133
    CrossRef

  459. 459

    Heike A Bischoff, Hannes B Stähelin, Walter Dick, Regula Akos, Margrith Knecht, Christian Salis, Matthias Nebiker, Robert Theiler, Michael Pfeifer, Bettina Begerow, Robert A Lew, Martin Conzelmann. (2003) Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial. Journal of Bone and Mineral Research 18:2, 343-351
    CrossRef

  460. 460

    Alan O. Malabanan, Michael F. Holick. (2003) Vitamin D and Bone Health in Postmenopausal Women. Journal of Women's Health 12:2, 151-156
    CrossRef

  461. 461

    Gianni Biolo, Martina Heer, Marco Narici, Felice Strollo. (2003) Microgravity as a model of ageing. Current Opinion in Clinical Nutrition and Metabolic Care 6:1, 31-40
    CrossRef

  462. 462

    Matthew R. Smith. (2003) Bisphosphonates to Prevent Osteoporosis in Men Receiving Androgen Deprivation Therapy for Prostate Cancer. Drugs & Aging 20:3, 175-183
    CrossRef

  463. 463

    &NA;. (2003) Secondary prevention of hip fractures should be standard care for patients who sustain a hip fracture. Drugs & Therapy Perspectives 19:1, 14-17
    CrossRef

  464. 464

    R. Wood. 2003. Osteoporosis. , 94-107.
    CrossRef

  465. 465

    J.J.B. Anderson, S.U. Toverud, S.C. Garner. 2003. RICKETS AND OSTEOMALACIA. , 5001-5006.
    CrossRef

  466. 466

    Rick L. Smith. (2003) Calcium and Vitamin D Supplementation in Nursing Home Residents. Journal of the American Medical Directors Association 4:Supplement, S24
    CrossRef

  467. 467

    A.A. Khan, J. Brown, K. Faulkner, D. Kendler, B. Lentle, W. Leslie, P.D. Miller, L. Nicholson, W.P. Olszynski, N.B. Watts, D. Hanley, A. Hodsman, R. Josse, T.M. Murray, K. Yuen. (2002) Standards and Guidelines for Performing Central Dual X-Ray Densitometry from the Canadian Panel of International Society for Clinical Densitometry. Journal of Clinical Densitometry 5:4, 435-445
    CrossRef

  468. 468

    Mark Clemons, Andrew Clamp, Beverley Anderson. (2002) Management of the menopause in cancer survivors. Cancer Treatment Reviews 28:6, 321-333
    CrossRef

  469. 469

    A.A. Khan, J. Brown, K. Faulkner, D. Kendler, B. Lentle, W. Leslie, P.D. Miller, L. Nicholson, W.P. Olszynski, N.B. Watts, D. Hanley, A. Hodsman, R. Josse, T.M. Murray, K. Yuen. (2002) Standards and Guidelines for Performing Central Dual X-Ray Densitometry from the Canadian Panel of International Society for Clinical Densitometry. Journal of Clinical Densitometry 5:3, 247-257
    CrossRef

  470. 470

    Leon Lenchik, Gary M. Kiebzak, Barbara A. Blunt. (2002) What Is the Role of Serial Bone Mineral Density Measurements in Patient Management?. Journal of Clinical Densitometry 5:3, s29-s38
    CrossRef

  471. 471

    Astrid Fahrleitner, Harald Dobnig, Andrea Obernosterer, Ernst Pilger, Georg Leb, Kurt Weber, Stefan Kudlacek, Barbara M. Obermayer-Pietsch. (2002) Vitamin D Deficiency and Secondary Hyperparathyroidism Are Common Complications in Patients with Peripheral Arterial Disease. Journal of General Internal Medicine 17:9, 663-669
    CrossRef

  472. 472

    R SAYEGH. (2002) Bone metabolism and the perimenopauseOverview, risk factors, screening, and osteoporosis preventive measures. Obstetrics and Gynecology Clinics of North America 29:3, 495-510
    CrossRef

  473. 473

    Alan Buchman, Anthony DeSantis. (2002) Current and emerging therapies in osteoporosis. Expert Opinion on Pharmacotherapy 3:7, 835-84
    CrossRef

  474. 474

    Y Sato, Y Honda, M Kaji, T Asoh, K Hosokawa, I Kondo, K Satoh. (2002) Amelioration of osteoporosis by menatetrenone in elderly female Parkinson’s disease patients with vitamin D deficiency. Bone 31:1, 114-118
    CrossRef

  475. 475

    Elizabeth Burgess, Mark S. Nanes. (2002) Osteoporosis in men: pathophysiology, evaluation, and therapy. Current Opinion in Rheumatology 14:4, 421-428
    CrossRef

  476. 476

    Pierre D Delmas. (2002) Treatment of postmenopausal osteoporosis. The Lancet 359:9322, 2018-2026
    CrossRef

  477. 477

    Ronny A. Bell, Sara A. Quandt, John G. Spangler, L.Douglas Case. (2002) Dietary calcium intake and supplement use among older African American, White, and Native American Women in a rural southeastern community. Journal of the American Dietetic Association 102:6, 844-847
    CrossRef

  478. 478

    R Marcus. (2002) Post-menopausal osteoporosis. Best Practice & Research Clinical Obstetrics & Gynaecology 16:3, 309-327
    CrossRef

  479. 479

    J. K. Dhesi, L. M. Bearne, C. Moniz, M. V. Hurley, S. H. D. Jackson, C. G. Swift, T. J. Allain. (2002) Neuromuscular and Psychomotor Function in Elderly Subjects Who Fall and the Relationship With Vitamin D Status. Journal of Bone and Mineral Research 17:5, 891-897
    CrossRef

  480. 480

    Ian R Reid. (2002) Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety. Expert Opinion on Drug Safety 1:1, 93-107
    CrossRef

  481. 481

    A.C Looker, B Dawson-Hughes, M.S Calvo, E.W Gunter, N.R Sahyoun. (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:5, 771-777
    CrossRef

  482. 482

    Richard Eastell, Helen Lambert. (2002) Plenary Lecture: Strategies for skeletal health in the elderly. Proceedings of the Nutrition Society 61:02, 173-180
    CrossRef

  483. 483

    Mark A Moyad. (2002) Complementary therapies for reducing the risk of osteoporosis in patients receiving luteinizing hormone-releasing hormone treatment/orchiectomy for prostate cancer: a review and assessment of the need for more research. Urology 59:4, 34-40
    CrossRef

  484. 484

    Sandra Bellantonio, George A Kuchel. (2002) Pharmacological approaches to cognitive deficits and incontinence (1899–2002): progress in geriatric care. Trends in Pharmacological Sciences 23:4, 192-193
    CrossRef

  485. 485

    Haakon E. Meyer, Guro B. Smedshaug, Elisabeth Kvaavik, Jan A. Falch, Aage Tverdal, Jan I. Pedersen. (2002) Can Vitamin D Supplementation Reduce the Risk of Fracture in the Elderly? A Randomized Controlled Trial. Journal of Bone and Mineral Research 17:4, 709-715
    CrossRef

  486. 486

    Jennifer Lange-Collett, Lorna Schumann. (2002) Promoting Health Among Perimenopausal Women through Diet and Exercise. Journal of the American Academy of Nurse Practitioners 14:4, 172-179
    CrossRef

  487. 487

    C. Simonelli, K. Killeen, S. Mehle, L. Swanson. (2002) Barriers to Osteoporosis Identification and Treatment Among Primary Care Physicians and Orthopedic Surgeons. Mayo Clinic Proceedings 77:4, 334-338
    CrossRef

  488. 488

    Susan A. New. (2002) Nutritional aspects of bone health: current focus and future directions. A review of conferences in 2000/2001. Nutrition Bulletin 27:1, 23-33
    CrossRef

  489. 489

    Anne Schaafsma, Jasper J. van Doormaal, Frits A. J. Muskiet, Gert J. H. Hofstede, Igor Pakan, Eveline van der Veer. (2002) Positive effects of a chicken eggshell powder-enriched vitamin–mineral supplement on femoral neck bone mineral density in healthy late post-menopausal Dutch women. British Journal of Nutrition 87:03, 267
    CrossRef

  490. 490

    Ada M. Lindsey, Gloria Gross, Jan Twiss, Nancy Waltman, Carol Ott, Timothy E. Moore. (2002) Postmenopausal Survivors of Breast Cancer at Risk for Osteoporosis: Nutritional Intake and Body Size. Cancer Nursing 25:1, 50-56
    CrossRef

  491. 491

    LOUISA T. LEE, WILLIAM M. DRAKE, DAVID L. KENDLER. (2002) Intake of calcium and vitamin D in 3 Canadian long-term care facilities. Journal of the American Dietetic Association 102:2, 244-247
    CrossRef

  492. 492

    S. H. Gehlbach, M. Fournier, C. Bigelow. (2002) Recognition of Osteoporosis by Primary Care Physicians. American Journal of Public Health 92:2, 271-273
    CrossRef

  493. 493

    Hosam K. Kamel, Edmund H. Duthie. (2002) The Underuse of Therapy in the Secondary Prevention of Hip Fractures. Drugs & Aging 19:1, 1-10
    CrossRef

  494. 494

    Michael Bolognese. (2002) Effective Pharmacotherapeutic Interventions for the Prevention of Hip Fractures. The Endocrinologist 12:1, 29-37
    CrossRef

  495. 495

    Alfredo Berruti, Marcello Tucci, Carlo Terrone, Gabriella Gorzegno, Roberto M. Scarpa, Alberto Angeli, Luigi Dogliotti. (2002) Background to and Management of Treatment-Related Bone Loss in Prostate Cancer. Drugs & Aging 19:12, 899-910
    CrossRef

  496. 496

    M.A Rodrı́guez-Martı́nez, E.C Garcı́a-Cohen. (2002) Role of Ca2+ and vitamin D in the prevention and treatment of osteoporosis. Pharmacology & Therapeutics 93:1, 37-49
    CrossRef

  497. 497

    Michel Brazier, S. Kamel, F. Lorget, M. Maamer, C. Tavera, N. Heurtebize, F. Grados, M. Mathieu, M. Garabedian, J.L. Sebert, P. Fardellone. (2002) Biological Effects of Supplementation with Vitamin D and Calcium in Postmenopausal Women with Low Bone Mass Receiving Alendronate. Clinical Drug Investigation 22:12, 849-857
    CrossRef

  498. 498

    Matthias Pirlich, Herbert Lochs. (2001) Nutrition in the elderly. Best Practice & Research Clinical Gastroenterology 15:6, 869-884
    CrossRef

  499. 499

    Elizabeth A. Krall. (2001) The Periodontal-Systemic Connection: Implications for Treatment of Patients With Osteoporosis and Periodontal Disease. Annals of Periodontology 6:1, 209-213
    CrossRef

  500. 500

    SHERRY SHERMAN. (2001) Preventing and Treating Osteoporosis. Annals of the New York Academy of Sciences 949:1, 188-197
    CrossRef

  501. 501

    Rick L. Smith. (2001) Calcium and Vitamin D Supplementation in Nursing Home Residents. Journal of the American Medical Directors Association 2:6, 289-296
    CrossRef

  502. 502

    Maike Wolters, Andreas Hahn. (2001) Der schmale Grat zwischen Prävention und Placebo: Nahrungsergänzungsmittel. Biologie in unserer Zeit 31:6, 367-375
    CrossRef

  503. 503

    S. M. F. Pluijm, M. Visser, J. H. Smit, C. Popp-Snijders, J. C. Roos, P. Lips. (2001) Determinants of Bone Mineral Density in Older Men and Women: Body Composition as Mediator. Journal of Bone and Mineral Research 16:11, 2142-2151
    CrossRef

  504. 504

    Jankees Ridder. (2001) Vitamine-D-deficiëntie, niet alleen bij migrantenvrouwen. Huisarts en Wetenschap 44:10, 295-298
    CrossRef

  505. 505

    Ayman A. A. Ewies. (2001) A Comprehensive Approach to the Menopause: So Far, One Size Should Fit All. Obstetrical and Gynecological Survey 56:10, 642-649
    CrossRef

  506. 506

    Adrianne Bendich. (2001) Micronutrients in women’s health and immune function. Nutrition 17:10, 858-867
    CrossRef

  507. 507

    Sandra Bellantonio, Richard Fortinsky, Karen Prestwood. (2001) How Well Are Community-Living Women Treated for Osteoporosis after Hip Fracture?. Journal of the American Geriatrics Society 49:9, 1197-1204
    CrossRef

  508. 508

    Harry W Daniell. (2001) Osteoporosis due to androgen deprivation therapy in men with prostate cancer. Urology 58:2, 101-106
    CrossRef

  509. 509

    Pedro Mezquita-Raya, Manuel Muñoz-Torres, Juan De Dios Luna, Victoria Luna, Francisca Lopez-Rodriguez, Elena Torres-Vela, Fernando Escobar-Jiménez. (2001) Relation Between Vitamin D Insufficiency, Bone Density, and Bone Metabolism in Healthy Postmenopausal Women. Journal of Bone and Mineral Research 16:8, 1408-1415
    CrossRef

  510. 510

    Erik Roj Larsen, Leif Mosekilde, Anders Foldspang. (2001) Determinants of acceptance of a community-based program for the prevention of falls and fractures among the elderly. Preventive Medicine 33:2, 115-119
    CrossRef

  511. 511

    I. Pande, R.M. Francis. (2001) Osteoporosis in men. Best Practice & Research Clinical Rheumatology 15:3, 415-427
    CrossRef

  512. 512

    LOIS D. McBEAN, SUSAN M. GROZIAK, GREGORY D. MILLER, JUDITH K. JARVIS. (2001) Healthy Eating in Later Years. Nutrition Today 36:4, 192-201
    CrossRef

  513. 513

    Chad L. Deal. (2001) Using bone densitometry to monitor therapy in treating osteoporosis: Pros and cons. Current Rheumatology Reports 3:3, 233-239
    CrossRef

  514. 514

    Neer, Robert M.Arnaud, Claude D.Zanchetta, Jose R.Prince, RichardGaich, Gregory A.Reginster, Jean-YvesHodsman, Anthony B.Eriksen, Erik F.Ish-Shalom, SophiaGenant, Harry K.Wang, OuhongMellström, DanOefjord, Erik S.Marcinowska-Suchowierska, EwaSalmi, JormaMulder, HenkHalse, JohanSawicki, Andrzej Z.Mitlak, Bruce H.. (2001) Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis. New England Journal of Medicine 344:19, 1434-1441
    Full Text

  515. 515

    Judith Morris, Ladislav Volicer. (2001) Nutritional Management of Individuals with Alzheimer's Disease and Other Progressive Dementias. Nutrition in Clinical Care 4:3, 148-155
    CrossRef

  516. 516

    Bernard Cortet, Jacques Vasseur, Bruno Grardel, Lionel Catanzariti, Xavier Marchandise, Bernard Delcambre. (2001) Management of male osteoporosis. Joint Bone Spine 68:3, 252-256
    CrossRef

  517. 517

    A. M. Kenny, K. M. Prestwood, C. A. Gruman, K. M. Marcello, L. G. Raisz. (2001) Effects of Transdermal Testosterone on Bone and Muscle in Older Men With Low Bioavailable Testosterone Levels. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 56:5, M266-M272
    CrossRef

  518. 518

    Mary Murimi. (2001) Short-Term Nutrition Intervention Increases Calcium Intake Among 45-54 Year Old Women. Journal of Nutrition For the Elderly 20:3, 1-12
    CrossRef

  519. 519

    &NA;. (2001) The role of calcium in peri-and postmenopausal women: consensus opinion of The North American Menopause Society. Menopause 8:2, 84-95
    CrossRef

  520. 520

    McClung, Michael R., Geusens, Piet, Miller, Paul D., Zippel, Hartmut, Bensen, William G., Roux, Christian, Adami, Silvano, Fogelman, Ignac, Diamond, Terrence, Eastell, Richard, Meunier, Pierre J., Wasnich, Richard D., Greenwald, Maria, Kaufman, Jean-Marc, Chesnut, Charles H., Reginster, Jean-Yves, . (2001) Effect of Risedronate on the Risk of Hip Fracture in Elderly Women. New England Journal of Medicine 344:5, 333-340
    Full Text

  521. 521

    J. Christopher Gallagher. (2001) Role of Estrogens in the Management of Postmenopausal Bone Loss. Rheumatic Disease Clinics of North America 27:1, 143-162
    CrossRef

  522. 522

    Shreyasee Amin, David T. Felson. (2001) Osteoporosis in Men. Rheumatic Disease Clinics of North America 27:1, 19-47
    CrossRef

  523. 523

    Sarah L. Morgan. (2001) Calcium and Vitamin D in Osteoporosis. Rheumatic Disease Clinics of North America 27:1, 101-130
    CrossRef

  524. 524

    Edward G. Lufkin, Mayme Wong, Chad Deal. (2001) The Role of Selective Estrogen Receptor Modulators in the Prevention and Treatment of Osteoporosis. Rheumatic Disease Clinics of North America 27:1, 163-185
    CrossRef

  525. 525

    E. Seeman. (2001) How Do Antiresorptive Agents Reduce Fracture Risk?. International Bone and Mineral Society Knowledge Environment 1:1, 2001012-0
    CrossRef

  526. 526

    G. J. Strewler. (2001) Calcium: Good for Your Bones, Good for Your Heart?. International Bone and Mineral Society Knowledge Environment 1:1, 2002061-0
    CrossRef

  527. 527

    Elizabeth A. Krall. (2001) The Oral Effects of Osteoporosis. Nutrition in Clinical Care 4:1, 22-27
    CrossRef

  528. 528

    Michelle M. Henshaw, Joseph M. Calabrese. (2001) Oral Health and Nutrition in the Elderly. Nutrition in Clinical Care 4:1, 34-42
    CrossRef

  529. 529

    Peter Vestergaard, Lars Rejnmark, Leif Mosekilde. (2001) Hip Fracture Prevention. PharmacoEconomics 19:Parts 1 and 2, 449-468
    CrossRef

  530. 530

    Anastasia M. Snelling, Carlos J. Crespo, Marc Schaeffer, Stephanie Smith, Leah Walbourn. (2001) Modifiable and Nonmodifiable Factors Associated with Osteoporosis in Postmenopausal Women: Results from the Third National Health and Nutrition Examination Survey, 1988–1994. Journal of Women's Health & Gender-Based Medicine 10:1, 57-65
    CrossRef

  531. 531

    Reinhold Vieth. (2001) Vitamin D Nutrition and its Potential Health Benefits for Bone, Cancer and Other Conditions. Journal of Nutritional and Environmental Medicine 11:4, 275-291
    CrossRef

  532. 532

    M. Kubota, S. Yoshida, M. Ikeda, Y. Okada, H. Arai, K. Miyamoto, E. Takeda. (2001) Association between two types of vitamin D receptor gene polymorphism and bone status in premenopausal Japanese women. Calcified Tissue International 68:1, 16-22
    CrossRef

  533. 533

    Eric S. Orwoll. (2000) Osteoporosis in men. Current Opinion in Endocrinology & Diabetes 7:6, 303-309
    CrossRef

  534. 534

    J.E Compston. (2000) Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?. Bone 27:6, 765-768
    CrossRef

  535. 535

    Yoshihiro Sato, Takeshi Asoh, Masahide Kaji, Kotaro Oizumi. (2000) Beneficial Effect of Intermittent Cyclical Etidronate Therapy in Hemiplegic Patients Following an Acute Stroke. Journal of Bone and Mineral Research 15:12, 2487-2494
    CrossRef

  536. 536

    Kannus, Pekka, Parkkari, Jari, Niemi, SeppoPasanen, Matti, Palvanen, Mika, Järvinen, Markku, Vuori, Ilkka, . (2000) Prevention of Hip Fracture in Elderly People with Use of a Hip Protector. New England Journal of Medicine 343:21, 1506-1513
    Full Text

  537. 537

    D Lee Alekel, Mark Messina, Eric Gugger. 2000. Soy Protein, Soybean Isoflavones, and Bone Health. .
    CrossRef

  538. 538

    Marc Hochberg. (2000) Preventing Fractures in Postmenopausal Women with Osteoporosis. Drugs & Aging 17:4, 317-330
    CrossRef

  539. 539

    Solveig A Hansen, Aaron R Folsom, Lawrence H Kushi, Thomas A Sellers. (2000) Association of fractures with caffeine and alcohol in postmenopausal women: the Iowa Women's Health Study. Public Health Nutrition 3:03,
    CrossRef

  540. 540

    M GASS, R REBAR. (2000) HORMONE REPLACEMENT FOR THE NEW MILLENNIUM. Obstetrics and Gynecology Clinics of North America 27:3, 611-623
    CrossRef

  541. 541

    Anne M. Kenny, Karen M. Prestwood. (2000) OSTEOPOROSIS. Rheumatic Disease Clinics of North America 26:3, 569-591
    CrossRef

  542. 542

    Frank H.J Wolfhagen, Henk R van Buuren, Frank P Vleggaar, Solko W Schalm. (2000) Management of osteoporosis in primary biliary cirrhosis. Best Practice & Research Clinical Gastroenterology 14:4, 629-641
    CrossRef

  543. 543

    W Andrews. (2000) Prevention and Treatment of Osteoporosis. ACOG Clinical Review 5:4, 1
    CrossRef

  544. 544

    SUSAN I BARR, DAVID A McCARRON, ROBERT P HEANEY, BESS DAWSON-HUGHES, SARAH L BERGA, JUDITH S STERN, SUZANNE OPARIL. (2000) Effects of Increased Consumption of Fluid Milk on Energy and Nutrient Intake, Body Weight, and Cardiovascular Risk Factors in Healthy Older Adults. Journal of the American Dietetic Association 100:7, 810-817
    CrossRef

  545. 545

    Mona S Calvo. (2000) Dietary considerations to prevent loss of bone and renal function. Nutrition 16:7-8, 564-566
    CrossRef

  546. 546

    MaryFran Sowers. (2000) Lower peak bone mass and its decline. Best Practice & Research Clinical Endocrinology & Metabolism 14:2, 317-329
    CrossRef

  547. 547

    Michael Pfeifer, Bettina Begerow, Helmut W. Minne, Christine Abrams, Detlef Nachtigall, Corinna Hansen. (2000) Effects of a Short-Term Vitamin D and Calcium Supplementation on Body Sway and Secondary Hyperparathyroidism in Elderly Women. Journal of Bone and Mineral Research 15:6, 1113-1118
    CrossRef

  548. 548

    Juliet Compston. (2000) Prevention of osteoporotic fractures in post-menopausal women. Best Practice & Research Clinical Endocrinology & Metabolism 14:2, 251-264
    CrossRef

  549. 549

    Dirk Vanderschueren, Steven Boonen, Roger Bouillon. (2000) Osteoporosis and osteoporotic fractures in men: a clinical perspective. Best Practice & Research Clinical Endocrinology & Metabolism 14:2, 299-315
    CrossRef

  550. 550

    N. de Jong, M. J. Paw, L. C. de Groot, G. J. Hiddink, W. A. van Staveren. (2000) Dietary supplements and physical exercise affecting bone and body composition in frail elderly persons. American Journal of Public Health 90:6, 947-954
    CrossRef

  551. 551

    Elizabeth Krall. 2000. Calcium and Vitamin D. , 173-181.
    CrossRef

  552. 552

    C. A. Inderjeeth, F. Nicklason, Y. Al-Lahham, T. M. Greenaway, G. Jones, V. V. Parameswaran, R. David. (2000) Vitamin D deficiency and secondary hyperparathyroidism: clinical and biochemical associations in older non-institutionalised Southern Tasmanians. Australian and New Zealand Journal of Medicine 30:2, 209-214
    CrossRef

  553. 553

    Joseph M. Lane, Linda Russell, Safdar N. Khan. (2000) Osteoporosis. Clinical Orthopaedics and Related Research 372, 139-150
    CrossRef

  554. 554

    A Johansen. (2000) Trauma in elderly people: what proportion of fractures are a consequence of bone fragility?. Archives of Gerontology and Geriatrics 29:3, 215-221
    CrossRef

  555. 555

    Randi L. Wolf, Katie L. Stone, Jane A. Cauley. (2000) Update on the epidemiology of osteoporosis. Current Rheumatology Reports 2:1, 74-86
    CrossRef

  556. 556

    E. A. M. de Deckere, P. M. Verschuren. 2000. Functional fats and spreads. , 233-257.
    CrossRef

  557. 557

    Trevor P. Rees, Ian Howe. (2000) A Randomised, Single-blind, Crossover Comparison of the Acceptability of the Calcium and Vitamin D3 Supplements Calcichew D3 Forte® and Ad Cal D3® in Elderly Patients. Current Medical Research and Opinion 16:4, 245-251
    CrossRef

  558. 558

    PETER J. VAN VELDHUIZEN, SARAH A. TAYLOR, STEPHEN WILLIAMSON, BETTY M. DREES. (2000) TREATMENT OF VITAMIN D DEFICIENCY IN PATIENTS WITH METASTATIC PROSTATE CANCER MAY IMPROVE BONE PAIN AND MUSCLE STRENGTH. The Journal of Urology 163:1, 187-190
    CrossRef

  559. 559

    Yoshihiro Sato. (2000) Abnormal bone and calcium metabolism in patients after stroke. Archives of Physical Medicine and Rehabilitation 81:1, 117-121
    CrossRef

  560. 560

    PETER J. VAN VELDHUIZEN, SARAH A. TAYLOR, STEPHEN WILLIAMSON, BETTY M. DREES. (2000) TREATMENT OF VITAMIN D DEFICIENCY IN PATIENTS WITH METASTATIC PROSTATE CANCER MAY IMPROVE BONE PAIN AND MUSCLE STRENGTH. The Journal of Urology187
    CrossRef

  561. 561

    David W. Dempster. (2000) The Contribution of Trabecular Architecture to Cancellous Bone Quality. Journal of Bone and Mineral Research 15:1, 20-23
    CrossRef

  562. 562

    Jenny Heathcote. (1999) Osteoporosis in chronic liver disease. Current Gastroenterology Reports 1:6, 455-458
    CrossRef

  563. 563

    Robert D. Blank, Richard S. Bockman. (1999) A Review of Clinical Trials of Therapies for Osteoporosis Using Fracture as an End Point. Journal of Clinical Densitometry 2:4, 435-452
    CrossRef

  564. 564

    D. Sudhaker Rao. (1999) Perspective on Assessment of Vitamin D Nutrition. Journal of Clinical Densitometry 2:4, 457-464
    CrossRef

  565. 565

    Sarah L. Booth, Miriam E. Nelson, Joel B. Mason, Giana Angelo, Simin Nikbin Meydani. (1999) Dietary Supplements for Peri- and Early Postmenopausal Women: A Quantitative Proposal Based on Disparities Between Recommendations and Dietary Intakes. Nutrition in Clinical Care 2:6, 361-371
    CrossRef

  566. 566

    Michael Pfeifer, Helmut W Minne. (1999) Vitamin D and Hip Fracture. Trends in Endocrinology & Metabolism 10:10, 417-420
    CrossRef

  567. 567

    Michael L. Power, Robert P. Heaney, Heidi J. Kalkwarf, Roy M. Pitkin, John T. Repke, Reginald C. Tsang, Jay Schulkin. (1999) The role of calcium in health and disease. American Journal of Obstetrics and Gynecology 181:6, 1560-1569
    CrossRef

  568. 568

    Jutta Krappweis, Anke Rentsch, Ute I. Schwarz, Karl J. Krobot, Wilhelm Kirch. (1999) Outpatient costs of osteoporosis in a national health insurance population. Clinical Therapeutics 21:11, 2001-2014
    CrossRef

  569. 569

    Katie L. Stone, Randi L. Wolfe. (1999) Diet, bone loss, and fracture risk: a review of the recent literature. Current Opinion in Orthopedics 10:5, 334-338
    CrossRef

  570. 570

    J. A. BARON, M. BEACH, J. S. MANDEL, R. U. STOLK, R. W. HAILE, R. S. SANDLER, R. ROTHSTEIN, R. W. SUMMERS, D. C. SNOVER, G. J. BECK, H. FRANKL, L. PEARSON, J. H. BOND, E. R. GREENBERG, . (1999) Calcium Supplements and Colorectal Adenomas. Annals of the New York Academy of Sciences 889:1 CANCER PREVEN, 138-145
    CrossRef

  571. 571

    1999. Contribution of Milk and Milk Products to Health Throughout the Life Cycle. .
    CrossRef

  572. 572

    C. Trivalle, R. Sebag-Lanoë, S. Guillemant. (1999) Prévention et traitement de l'insuffisance en vitamine D du sujet âgé: une efficacité prouvée. La Revue de Médecine Interne 20:9, 755-758
    CrossRef

  573. 573

    Sanjeev Bakshi, Douglas K. Miller. (1999) ASSESSMENT OF THE AGING MAN. Medical Clinics of North America 83:5, 1131-1149
    CrossRef

  574. 574

    Craig D. Rubin. (1999) Southwestern Internal Medicine Conference. The American Journal of the Medical Sciences 318:3, 158
    CrossRef

  575. 575

    Yoshihiro Sato, Haruko Kuno, Masahide Kaji, Naoko Saruwatari, Kotaro Oizumi. (1999) EFFECT OF IPRIFLAVONE ON BONE IN ELDERLY HEMIPLEGIC STROKE PATIENTS WITH HYPOVITAMINOSIS D1. American Journal of Physical Medicine & Rehabilitation 78:5, 457-463
    CrossRef

  576. 576

    Horace M. Perry, M. Horowitz, J.E. Morley, Ping Patrick, Bruno Vellas, Richard Baumgartner, Phillip J. Garry. (1999) Longitudinal changes in serum 25-hydroxyvitamin D in older people. Metabolism 48:8, 1028-1032
    CrossRef

  577. 577

    O. Sahota, T. Masud, P. San, D. J. Hosking. (1999) Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis. Clinical Endocrinology 51:2, 217-221
    CrossRef

  578. 578

    Nathaniel W Liggett, David M Reid. (1999) The non-hormonal treatment of osteoporosis. The Obstetrician & Gynaecologist 1:1, 7-11
    CrossRef

  579. 579

    Yoshihiro Sato, Toshiomi Tsuru, Kotaro Oizumi, Masahide Kaji. (1999) VITAMIN K DEFICIENCY AND OSTEOPENIA IN DISUSE-AFFECTED LIMBS OF VITAMIN D-DEFICIENT ELDERLY STROKE PATIENTS1. American Journal of Physical Medicine & Rehabilitation 78:4, 317-322
    CrossRef

  580. 580

    R. Rizzoli, J.-P. Bonjour. (1999) Unterernährung und Osteoporose*. Zeitschrift für Gerontologie und Geriatrie 32:S1, S31-S37
    CrossRef

  581. 581

    Richard L. Prince. (1999) Osteoporosis Detection and Treatment. Journal of Clinical Densitometry 2:2, 105-107
    CrossRef

  582. 582

    (1999) Position of The American Dietetic Association and Dietitians of Canada. Journal of the American Dietetic Association 99:6, 738-751
    CrossRef

  583. 583

    Adrianne Bendich, Shelah Leader, Pradip Muhuri. (1999) Supplemental calcium for the prevention of hip fracture: Potential health-economic benefits. Clinical Therapeutics 21:6, 1058-1072
    CrossRef

  584. 584

    ELLEN R BROOKS, PAULA M HOWAT, DEBORAH S CAVALIER. (1999) Calcium Supplementation and Exercise Increase Appendicular Bone Density in Anorexia. Journal of the American Dietetic Association 99:5, 591-593
    CrossRef

  585. 585

    J.F. MAILLEFERT, J. SIBILIA, F. MICHEL, C. SAUSSINE, R.M. JAVIER, C. TAVERNIER. (1999) BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMA. The Journal of Urology 161:4, 1219-1222
    CrossRef

  586. 586

    J. F. MAILLEFERT, J. SIBILIA, F. MICHEL, C. SAUSSINE, R. M. JAVIER, C. TAVERNIER. (1999) BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMA. The Journal of Urology1219-1222
    CrossRef

  587. 587

    Rachel Dowd, R. Jennifer Cavalieri. (1999) Help Your Patient Live with OSTEOPOROSIS. American Journal of Nursing 99:4, 55
    CrossRef

  588. 588

    Tanya Agurs-Collins, E. Lea Watson. (1999) Weight, Nutrition, Lifestyle Factors and Risk for Osteoporosis. Journal of Nutrition For the Elderly 18:1, 15-26
    CrossRef

  589. 589

    Juliet E. Compston. (1999) Bone Densitometry and Clinical Decision Making. Journal of Clinical Densitometry 2:1, 5-9
    CrossRef

  590. 590

    Y Sato, K Oizumi, H Kuno, M Kaji. (1999) Effect of immobilization upon renal synthesis of 1,25-dihydroxyvitamin D in disabled elderly stroke patients. Bone 24:3, 271-275
    CrossRef

  591. 591

    Elizabeth A. Krall, Bess Dawson-Hughes. (1999) Smoking Increases Bone Loss and Decreases Intestinal Calcium Absorption. Journal of Bone and Mineral Research 14:2, 215-220
    CrossRef

  592. 592

    Baron, J.A., Beach, M., Mandel, J.S., van Stolk, R.U., Haile, R.W., Sandler, R.S., Rothstein, R., Summers, R.W., Snover, D.C., Beck, G.J., Bond, J.H., Frankl, H., Pearson, L., Greenberg, E.R., . (1999) Calcium Supplements for the Prevention of Colorectal Adenomas. New England Journal of Medicine 340:2, 101-107
    Full Text

  593. 593

    Nutthapong Tangsinmankong, Sami L Bahna, Robert A Good. (1999) Osteoporosis for the allergist. Annals of Allergy, Asthma & Immunology 82:1, 5-14
    CrossRef

  594. 594

    Mary Beth O’Connell. (1999) Prevention and Treatment of Osteoporosis in the Elderly. Pharmacotherapy 19:1 Part 2, 7S-20S
    CrossRef

  595. 595

    JENNIFER E. LAYNE, MIRIAM E. NELSON. (1999) The effects of progressive resistance training on bone density: a review. Medicine & Science in Sports & Exercise 31:1, 25-30
    CrossRef

  596. 596

    Piet Geusens, Steven Boonen. (1998) Risk Assessment for Osteoporosis Using Bone Mineral Density Determination. Journal of Clinical Densitometry 1:4, 355-358
    CrossRef

  597. 597

    Gordon H. Guyatt. (1998) Evidence-Based Management of Patients with Osteoporosis. Journal of Clinical Densitometry 1:4, 395-402
    CrossRef

  598. 598

    John D Termine, Mayme Wong. (1998) Post-menopausal women and osteoporosis: available choices for maintenance of skeletal health. Maturitas 30:3, 241-245
    CrossRef

  599. 599

    Coen Netelenbos. (1998) Osteoporosis: intervention options. Maturitas 30:3, 235-239
    CrossRef

  600. 600

    Serge Ferrari, Jean-Philippe Bonjour, René Rizzoli. (1998) The Vitamin D Receptor Gene and Calcium Metabolism. Trends in Endocrinology & Metabolism 9:7, 259-265
    CrossRef

  601. 601

    Paula J. Rackoff, Clifford J. Rosen. (1998) Peripheral Bone Mass Measurements. Journal of Clinical Densitometry 1:3, 287-294
    CrossRef

  602. 602

    S. E. Gariballa, A. J. Sinclair. (1998) Nutrition, ageing and ill health. British Journal of Nutrition 80:01, 7
    CrossRef

  603. 603

    Jeanne P. Goldberg, Julie A. Smith, Christina Economos. (1998) Dietary Management of the "Old-Old": An Individualized Approach. Nutrition in Clinical Care 1:3, 126-137
    CrossRef

  604. 604

    Kimberly O. O'Brien. (1998) Combined Calcium and Vitamin D Supplementation Reduces Bone Loss and Fracture Incidence in Older Men and Women. Nutrition Reviews 56:5, 148-150
    CrossRef

  605. 605

    B. Lawrence Riggs, Sundeep Khosla, L. Joseph Melton. (1998) A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men. Journal of Bone and Mineral Research 13:5, 763-773
    CrossRef

  606. 606

    Suceso Docio, José A. Riancho, Amabilia Pérez, José M. Olmos, José A. Amado, Jesús González-Macías. (1998) Seasonal Deficiency of Vitamin D in Children: A Potential Target for Osteoporosis-Preventing Strategies?. Journal of Bone and Mineral Research 13:4, 544-548
    CrossRef

  607. 607

    Yoshihiro Sato, Yukiko Fujimatsu, Munetsugu Kikuyama, Masahide Kaji, Kotaro Oizumic. (1998) Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke. Journal of the Neurological Sciences 156:2, 205-210
    CrossRef

  608. 608

    Utiger, Robert D., . (1998) The Need for More Vitamin D. New England Journal of Medicine 338:12, 828-829
    Full Text

  609. 609

    Thomas, Melissa K., Lloyd-Jones, Donald M., Thadhani, Ravi I., Shaw, Albert C., Deraska, Donald J., Kitch, Barrett T., Vamvakas, Eleftherios C., Dick, Ian M., Prince, Richard L., Finkelstein, Joel S., . (1998) Hypovitaminosis D in Medical Inpatients. New England Journal of Medicine 338:12, 777-783
    Full Text

  610. 610

    Wood, Alastair J.J., , Eastell, Richard, . (1998) Treatment of Postmenopausal Osteoporosis. New England Journal of Medicine 338:11, 736-746
    Full Text

  611. 611

    A Malabanan, IE Veronikis, MF Holick. (1998) Redefining vitamin D insufficiency. The Lancet 351:9105, 805-806
    CrossRef

  612. 612

    J. Christopher Gallagher, H. Karimi Kinyamu, Sarah E. Fowler, Bess Dawson-Hughes, Gail P. Dalsky, Sherry S. Sherman. (1998) Calciotropic Hormones and Bone Markers in the Elderly. Journal of Bone and Mineral Research 13:3, 475-482
    CrossRef

  613. 613

    Clifford J Rosen. (1998) Pre-emptive bone strikes in prevention of osteoporosis. The Lancet 351:9107, 927-928
    CrossRef

  614. 614

    R. M. Francis. (1998) Management of established osteoporosis. British Journal of Clinical Pharmacology 45:2, 95-99
    CrossRef

  615. 615

    Karl J Obrant. (1998) Prevention of osteoporotic fractures-should orthopedic surgeons care?. Acta Orthopaedica 69:4, 333-338
    CrossRef

  616. 616

    Roberta Bourgon. (1997) Osteoporosis and Nutrition. Alternative and Complementary Therapies 3:6, 433-440
    CrossRef

  617. 617

    Prince, Richard L., . (1997) Diet and the Prevention of Osteoporotic Fractures. New England Journal of Medicine 337:10, 701-702
    Full Text